Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 11.7;WM-115: 22.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"				"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: , HPA053288: "	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	11.7	0.0	0.5	2.2	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.7	0.2	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"			22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: "	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	10.0	2.0	12.6	14.1	5.0	12.4	3.7	3.5	4.1	4.1	15.3	2.2	0.1	19.3	3.6	21.6	0.2	1.5	1.3	6.4	2.2	15.6	11.0	28.2	17.0	0.0	5.2	7.4	1.8	2.7	0.0	7.2	13.3	1.9	2.8	5.1	1.0	0.1	3.2	4.1	5.2	6.4	0.6	2.2	0.2	7.4	7.9	7.8	18.5	8.2	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.1	4.0	0.0	6.3	0.1	7.4	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			19000000	"Nucleoli, Mitochondria"	"Nucleoplasm, Cytosol"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.2	31.9	13.1	18.0	56.6	20.8	24.8	24.5	34.1	28.0	17.4	12.9	30.2	17.8	20.5	51.4	25.7	8.8	26.8	24.8	56.5	9.0	9.5	22.7	19.6	27.2	9.0	24.8	23.2	24.6	23.4	36.9	25.1	12.2	21.8	44.9	12.6	9.4	10.9	6.2	12.6	13.1	14.5	42.4	62.2	30.4	3.5	8.6	34.6	44.0	20.1	20.2	13.9	25.0	24.8	18.6	12.5	23.9	20.4	9.5	0.9	45.6	16.0	18.0	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.2;U-2 OS: 4.9;U-2197: 9.1;U-87 MG: 4.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"			"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.6	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.2	3.3	0.0	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.9	0.1	0.0	0.3	0.1	0.0	0.0	6.2	0.2	0.0	0.8	0.4	1.2	0.1	0.1	0.3	1.7	2.5	0.5	3.3	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	3.3	4.9	9.1	2.1	0.5	0.2	0.1	4.7	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Group enriched"	"Detected in some"	4	"A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: "	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	134.6	0.1	14.2	167.1	5.7	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	3.8	0.0	0.7	0.0	0.0	0.0	0.0	38.0	251.2	0.3	0.0	0.0	14.9	8.4	0.7	0.7	0.0	5.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.2	76.9	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.9	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell line enhanced"	"Detected in many"		"A549: 149.2;AN3-CA: 43.6;ASC diff: 85.8;HeLa: 46.2;Hep G2: 62.6;RT4: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdT-cell: 26.7"	"Low lineage specificity"	"Detected in many"											"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			11000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: "	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	149.2	0.1	43.6	85.8	30.9	0.0	0.0	2.1	0.0	0.1	4.4	2.5	0.0	8.1	2.0	1.2	0.1	2.9	0.0	0.3	0.0	0.2	46.2	62.6	0.4	0.0	0.0	17.1	6.1	2.0	0.0	2.8	0.9	0.0	3.9	0.3	1.0	0.2	0.0	0.4	0.3	0.9	4.4	14.7	58.9	0.0	0.3	21.4	0.0	0.0	0.0	0.0	20.8	0.5	0.4	9.0	0.3	0.0	0.0	0.0	5.0	5.9	0.4	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 11.8"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: , HPA068265: "	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: , HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 62.2;U-266/70: 42.9"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"			280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavourable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.4	0.5	3.5	14.4	7.2	7.4	0.7	3.8	8.6	2.9	18.1	4.3	0.7	3.5	4.6	3.4	9.7	2.3	23.6	5.5	3.0	2.2	6.7	2.7	7.4	6.8	2.4	7.8	6.8	3.3	0.3	5.9	1.3	4.6	18.8	2.5	3.5	2.8	8.1	5.4	3.9	2.4	0.4	62.2	0.4	1.0	9.2	16.4	2.2	17.7	0.1	9.6	5.5	0.9	0.3	1.4	0.5	0.6	42.9	12.3	2.6	28.1	7.0	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	18	"HEL: 27.6;K-562: 15.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	"Nucleoplasm,Vesicles,Centriolar satellite,Cytosol"				Vesicles	"Nucleoplasm, Centriolar satellite, Cytosol"	"HPA060228: , HPA069636: "	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	27.6	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			39000	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: "	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favourable (6.41e-4)"	"unprognostic (7.56e-3)"	19.2	29.6	28.8	32.9	29.1	51.1	17.9	34.0	37.5	19.6	16.8	26.6	20.0	17.4	23.7	20.0	21.1	30.3	26.1	20.3	27.7	14.4	20.9	16.6	35.5	27.8	27.5	17.8	28.8	18.9	14.3	31.0	20.9	23.0	21.3	11.2	18.1	19.9	19.0	12.9	27.5	23.6	17.1	25.6	53.8	16.2	23.5	32.3	18.8	24.7	14.0	18.6	28.4	19.6	3.3	7.4	24.0	22.5	6.1	4.4	6.4	7.1	15.1	5.8	7.0	24.8	16.8	8.7	9.8	17.7	11.2	11.1	20.7	19.0	15.8	19.8	16.5	24.1	8.8	23.4	4.8	18.6	10.3	13.4	14.3	28.5	17.2	9.1	37.7	17.9	24.9	18.3	8.8	11.8	11.2	6.4	5.2	14.7	13.8	31.8	3.6	9.8	13.5	8.8	7.7	10.4	22.8	6.0	12.3	7.1	10.6	31.6	9.3	20.8	14.0	15.9	11.0	16.1	6.0	10.3	5.0	8.3	8.4	13.7	8.4	7.5	11.0	13.3	4.4	18.7	2.6	3.3	2.9	3.3	7.4	2.6	2.3	2.7	24.0	6.1	22.5	2.5	3.1	6.4	28.8	29.1	34.0	37.5	27.7	14.4	27.5	17.8	23.0	32.3
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 47.6;hTERT-HME1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	38	"monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	28.1	3.2	7.2	6.8	10.6	0.3	24.4	34.9	11.5	11.9	7.4	2.3	9.0	2.8	10.3	8.1	6.9	8.2	9.1	15.9	7.8	5.2	27.7	21.1	23.0	8.2	6.7	3.6	11.5	6.5	12.8	7.4	22.9	10.0	12.2	4.7	11.7	20.7	10.4	10.3	13.5	5.4	8.0	6.4	26.0	8.8	7.7	7.0	2.2	22.7	8.9	3.8	10.6	14.8	0.0	0.0	0.0	3.7	0.0	0.0	0.3	47.6	2.0	2.9	0.0	10.4	24.7	10.6	16.0	26.1	13.6	19.8	5.7	2.4	0.0	36.1	32.1	10.2	0.1	10.9	28.0	0.0	1.5	0.2	2.7	2.5	1.0	0.0	0.0	4.8	2.0	10.3	43.0	36.5	0.0	0.0	13.4	1.6	0.9	0.0	3.9	32.9	0.6	2.4	0.0	28.6	4.2	0.0	0.6	9.8	7.7	0.7	2.3	0.1	32.8	8.2	11.3	12.6	12.3	0.0	0.0	0.0	1.6	0.0	0.4	0.0	1.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	7.2	10.6	34.9	11.5	7.8	5.2	6.7	3.6	10.0	7.0
ARHGAP39	"CrGAP, KIAA1688, Vilse"	ENSG00000147799	"Rho GTPase activating protein 39"	Q9C0H5	8	144529179-144605816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044491			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Nucleoplasm, Microtubules, Cytokinetic bridge"	"HPA044491: AB_10794775"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-7)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.97e-2)"	1.1	1.9	3.6	1.0	3.5	0.0	1.2	6.2	7.0	2.0	2.0			2.4	1.7	1.2	1.4	7.0	0.9	0.4	5.3	4.4	1.8	0.2	1.5	0.3	3.3		0.9	2.9	2.0	4.0	0.9		2.1	0.9		3.5	2.3	0.6	2.6	2.4	0.6	7.2	0.9	1.2	12.8			2.8		0.1	0.5	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	7.5	7.5	3.5	5.5	0.7	0.6	6.8	1.9	0.6	2.4	1.6	4.8	4.5	0.7	5.1	0.8	6.4	1.7	1.9	0.5	0.0	6.7	0.1	4.9	3.0	1.2	0.0	0.7	0.5	3.1	3.2	1.3	0.8	6.9	0.0	1.0	12.1	4.1	0.0	3.7	10.7	3.8	2.8	2.8	1.9	3.8	10.3	7.3	5.7	2.0	3.4	8.4	1.1	1.9	1.8	0.1	6.2	4.1	0.0	0.1	0.3	3.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	11.3	0.0	13.7	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901300-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	43.3	5.6	7.8	13.8	9.9	4.2	22.6	3.3	11.5	27.5	14.0	9.5	4.4	6.8	29.4	10.4	14.0	15.6	27.2	16.0	5.9	5.1	14.6	5.7	14.6	14.4	11.8	6.5	18.6	4.3	14.7	11.4	22.4	9.4	16.6	8.2	6.9	14.5	7.3	88.6	15.0	12.1	29.4	10.4	12.7	9.4	7.7	10.5	8.6	7.5	11.7	18.0	22.5	17.1	21.2	1.0	4.3	3.6	5.7	14.7	2.6	0.8	0.3	2.3	5.7	5.1	13.7	0.4	16.6	44.8	11.8	9.3	20.1	0.9	1.4	4.0	15.9	5.5	8.0	2.5	14.3	5.2	2.4	0.7	4.1	5.0	9.5	0.2	9.9	17.3	1.3	7.0	8.0	1.4	0.7	2.2	3.8	2.8	5.4	0.4	0.4	5.2	6.6	3.8	0.4	7.8	9.0	1.3	1.7	7.4	4.1	4.8	3.4	0.2	1.2	6.6	8.9	9.9	4.2	0.1	0.0	4.3	5.7	0.3	2.1	4.3	0.6	0.4	7.3	1.4	0.9	19.0	10.5	6.3	1.0	21.2	6.9	4.5	1.2	5.7	3.6	0.5	14.7	2.6	7.8	9.9	3.3	11.5	5.9	5.1	11.8	6.5	9.4	10.5
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323051-30338227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"				"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: , HPA048127: AB_2680277"	"prognostic favourable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favourable (7.49e-4)"	13.9	21.5	24.5	12.9	29.1	6.3	18.7	22.7	23.4	17.0	14.5	8.0	22.4	8.7	18.1	22.7	11.1	15.8	12.4	20.5	17.7	15.5	16.5	17.6	10.3	23.5	15.5	20.5	20.1	15.0	33.4	28.6	10.6	15.1	19.0	10.3	9.0	17.0	19.9	28.0	11.6	12.5	18.3	16.0	18.2	14.4	14.5	15.0	11.6	23.3	13.9	19.1	16.1	15.1	17.6	12.7	5.5	9.6	24.4	28.7	11.2	5.7	8.3	9.3	8.2	15.3	16.6	4.7	11.2	14.2	10.2	11.3	4.6	2.2	23.4	7.7	8.1	9.7	13.5	9.5	14.5	18.5	16.8	7.0	6.6	8.0	24.1	12.6	8.1	17.2	19.2	4.8	18.3	11.2	11.1	12.8	17.8	5.4	11.3	10.4	10.8	11.6	10.0	22.8	9.5	13.7	8.0	10.6	11.3	8.8	11.7	13.8	12.5	7.1	9.8	11.7	6.2	23.0	10.6	20.0	11.3	15.2	11.2	7.9	11.1	5.5	9.6	3.0	12.1	9.4	28.7	17.6	14.8	13.4	12.7	14.0	13.7	13.1	1.7	24.4	7.0	9.1	9.5	11.2	24.5	29.1	22.7	23.4	17.7	15.5	15.5	20.5	15.1	15.0
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014113-65022184	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"				Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favourable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	39.6	32.0	37.3	17.7	78.7	19.8	26.8	16.1	46.5	21.2	23.5	34.7	13.4	23.9	26.8	20.2	23.7	35.2	22.4	52.6	34.8	32.7	33.8	6.6	23.1	14.8	36.1	38.2	27.2	29.9	22.5	15.4	25.5	32.7	25.3	15.5	30.3	26.9	33.1	78.3	19.6	23.4	28.2	44.9	16.7	18.9	31.4	28.7	7.9	26.3	23.6	12.9	24.7	22.8	43.7	37.8	18.7	21.8	21.0	40.7	34.7	35.8	57.1	17.7	26.2	48.1	36.6	16.1	17.7	40.9	25.4	25.1	16.1	24.8	13.8	33.8	24.9	23.0	18.6	31.1	12.1	14.5	29.2	13.9	25.8	24.3	36.9	16.9	12.7	28.8	26.1	21.1	47.4	33.7	32.9	25.9	17.0	42.4	14.0	38.1	27.7	46.7	7.4	19.4	33.3	27.3	15.6	33.0	18.6	15.1	15.7	49.7	16.5	20.8	25.3	47.8	16.1	38.0	18.2	8.9	12.5	8.5	22.6	24.5	38.8	10.2	21.8	18.7	34.8	21.2	37.6	43.7	32.2	33.6	27.6	37.3	36.8	40.7	2.8	21.0	12.4	37.8	20.6	34.7	37.3	78.7	16.1	46.5	34.8	32.7	36.1	38.2	32.7	28.7
ASIC4	"ACCN4, BNAC4"	ENSG00000072182	"Acid sensing ion channel subunit family member 4"	Q96FT7	2	219514170-219538772	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.7;pituitary gland: 20.6"	"Group enriched"	"Detected in some"	30	"HEL: 18.7;HMC-1: 5.6;K-562: 10.7;SH-SY5Y: 5.1"	"Cancer enriched"	"Detected in single"	38	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 65.5"	"Low region specificity"	"Detected in many"			"HPA036042, HPA057078"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite"				"Golgi apparatus, Centriolar satellite"	"Nucleoplasm, Plasma membrane"	"HPA036042: AB_10672998, HPA057078: "	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-8)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.48e-2)"	0.8	3.3	4.9	0.6	4.7	0.5	0.6	6.9	17.7	1.0	0.5	1.6	0.0	0.5	0.8	0.6	0.5	0.6	0.6	0.6	3.9	4.5	0.5	0.6	0.9	0.6	4.8	2.9	0.5	0.5	0.5	20.6	0.6	3.0	0.6	0.5	4.9	0.6	0.8	0.5	0.6	0.5	0.7	1.9	0.6	0.7	1.6	3.1	0.0	0.5	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.7	6.9	4.9	3.9	4.5	4.8	2.9	3.0	3.1
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family, AAA domain containing 5"	Q96QE3	17	30831970-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.0;lymphoid tissue: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"			Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	2.0	1.2	1.1	8.1	3.8	19.0	2.4	9.6	3.2	2.7	3.3	1.2	0.7	2.8	2.1	2.5	4.0	2.0	1.7	1.4	1.8	1.3	1.9	1.4	2.3	6.4	1.9	2.7	3.0	1.7	1.3	3.1	5.3	2.3	1.8	3.1	0.6	2.1	1.2	1.3	4.5	3.4	1.5	1.5	6.3	2.2	4.0	2.6	29.9	1.8	2.7	5.3	1.8	2.7	2.3	2.1	3.1	1.3	3.0	1.6	0.3	4.8	4.0	9.5	9.0	0.2	1.0	3.8	4.2	2.1	4.7	6.8	4.4	3.4	12.9	4.1	1.9	8.8	6.1	3.2	8.6	2.9	5.3	7.8	5.2	3.0	0.1	15.1	6.3	0.4	0.4	6.9	2.4	2.4	12.1	10.8	3.1	2.8	16.8	7.5	5.6	1.9	11.6	18.1	6.1	1.2	5.1	5.6	5.0	4.7	2.7	2.5	5.1	6.7	1.9	5.9	7.9	8.2	7.5	3.6	3.7	16.2	2.5	7.2	5.7	1.2	1.0	1.4	1.6	1.3	0.9	1.2	0.9	1.2	0.7	2.3	1.1	1.2	3.1	3.0	0.6	2.1	1.4	0.3	1.1	3.8	9.6	3.2	1.8	1.3	1.9	2.7	2.3	2.6
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;HBF TERT88: 24.3;RT4: 57.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favourable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.1	3.4	0.1	0.1	3.5	6.4	4.9	19.6	19.1	20.6	12.9	2.6	8.8	0.7	5.9	27.1	15.0	0.1	4.1	24.3	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.7	6.2	10.9	10.8	0.1	0.4	11.9	4.8	0.2	0.2	0.2	1.0	0.1	0.1	0.2	2.8	57.5	0.4	0.3	0.4	12.1	0.1	3.7	0.6	12.4	16.8	0.6	2.7	4.5	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3										
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369796-382116	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1;ovary: 18.6"	"Cell line enhanced"	"Detected in many"		"AF22: 19.7;NTERA-2: 17.6;SCLC-21H: 21.9;SH-SY5Y: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053126	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"	"Intracellular and membrane"			"Nucleoplasm, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA053126: "	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	1.6	2.5	20.6	2.8	16.7	1.2	3.5	26.5	35.1	5.9	2.0	8.6	0.8	2.4	8.6	2.4	1.8	8.7	2.1	1.4	17.6	16.8	1.2	1.1	1.3	1.6	11.5	14.9	18.6	1.8	6.3	6.1	1.1	13.0	3.8	1.6	2.3	4.0	3.7	1.1	3.8	2.9	3.1	8.3	1.5	1.5	1.8	11.0	0.0	1.1	0.0	1.7	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	19.7	11.3	0.0	0.0	4.6	3.5	0.9	1.6	0.5	2.0	0.0	0.0	2.6	0.4	0.7	2.6	4.7	0.5	0.0	6.7	0.0	6.2	6.1	0.2	0.0	4.8	0.3	2.8	0.1	2.1	0.2	6.0	0.0	0.0	5.8	0.2	0.0	17.6	7.7	0.0	0.0	2.6	0.2	0.0	21.9	26.7	1.3	0.9	0.2	7.7	0.0	4.8	1.1	6.3	1.9	0.2	0.0	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	16.7	26.5	21.2	17.6	16.8	11.5	14.9	13.0	11.0
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321211-22331484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 87.1;U-937: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: , HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	19.7	23.5	28.0	17.0	35.0	13.3	26.5	26.1	33.7	21.6	22.3	26.3	11.6	14.1	23.9	22.8	16.0	17.0	17.4	15.1	28.3	24.2	19.2	25.5	16.7	17.9	42.3	27.7	18.8	18.6	40.0	37.6	20.6	24.8	25.5	16.0	16.5	15.7	20.3	28.5	10.3	14.6	26.3	34.8	24.6	16.5	24.3	40.7	12.9	17.6	10.6	18.8	21.5	25.9	5.0	1.8	13.0	3.4	6.2	8.4	2.4	12.7	6.2	7.1	2.2	12.5	10.1	7.2	8.6	3.9	6.6	7.8	6.5	16.0	6.5	5.9	7.8	4.5	10.3	6.1	8.2	87.1	12.8	18.0	5.3	7.3	7.5	6.6	10.0	6.5	10.6	7.2	8.0	4.6	17.8	11.1	8.7	5.1	17.8	1.9	1.6	14.8	13.3	10.2	6.2	6.2	4.2	6.0	11.9	5.7	7.5	9.6	6.7	26.7	9.8	7.4	22.2	17.7	11.6	13.7	17.8	14.4	10.5	102.3	4.8	13.0	1.5	2.5	6.1	3.4	8.4	5.0	6.4	5.8	1.0	2.6	5.5	5.2	0.6	6.2	2.1	1.8	4.3	2.4	28.0	35.0	26.1	33.7	28.3	24.2	42.3	27.7	24.8	40.7
C16orf58	FLJ13868	ENSG00000140688	"Chromosome 16 open reading frame 58"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"				"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	13.5	17.7	15.9	15.3	22.3	11.0	15.7	17.9	30.8	22.6	17.5	16.6	34.2	18.6	24.2	21.4	16.8	21.0	20.0	16.7	12.9	15.3	19.1	51.0	13.9	15.7	13.8	16.4	29.5	49.1	30.7	27.6	23.1	13.1	22.0	11.6	22.9	36.9	26.7	4.8	14.1	22.2	15.6	9.1	12.9	19.7	11.9	14.3	15.1	26.4	14.2	19.3	15.9	17.4	8.9	12.0	8.8	9.8	10.8	11.3	8.4	11.4	15.2	9.5	16.5	22.1	14.8	17.6	13.7	23.5	10.7	12.8	4.6	20.2	9.8	29.2	20.2	16.0	9.5	12.7	5.0	14.3	9.4	10.0	8.6	11.4	32.1	11.7	12.0	17.8	13.8	14.1	29.0	10.3	14.7	17.0	10.4	21.6	5.4	7.8	7.4	10.0	12.4	14.3	29.7	12.2	7.1	10.4	16.0	10.3	27.2	21.4	23.5	17.3	8.9	18.7	10.5	12.0	8.9	24.8	14.4	7.4	23.9	18.0	25.7	3.8	6.9	8.8	10.3	9.8	9.6	8.9	10.7	10.2	12.0	8.5	10.8	9.3	1.2	10.8	9.6	11.0	11.3	8.4	15.9	22.3	17.9	30.8	12.9	15.3	13.8	16.4	13.1	14.3
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.1"	"Cell line enhanced"	"Detected in all"		"HMC-1: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011044	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				"Nucleoplasm, Nucleoli"	"Nuclear membrane, Cytosol"	"HPA011044: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favourable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	5.2	7.0	15.9	7.3	33.1	14.7	4.8	18.2	31.2	5.8	10.3	7.5	8.3	18.7	4.1	6.1	9.4	10.9	6.3	7.9	15.8	13.6	6.3	7.3	8.3	8.5	9.1	12.6	3.9	7.5	7.8	14.2	4.8	11.7	4.8	8.8	5.6	8.7	7.0	8.3	12.5	19.4	6.1	7.3	9.2	5.5	2.6	9.1	7.0	5.5	6.7	6.6	6.6	5.3	0.4	1.1	5.7	4.2	1.7	1.6	1.1	3.3	2.5	3.5	7.1	4.5	1.9	2.2	5.1	4.5	5.1	4.3	4.0	3.5	5.1	13.4	3.5	7.6	4.3	2.2	2.0	8.0	3.6	20.0	3.2	2.9	6.0	5.7	29.2	2.2	4.5	9.5	3.5	3.2	8.3	9.1	4.7	8.9	6.4	13.8	1.3	6.8	4.1	3.1	5.8	5.0	2.1	10.7	6.1	2.1	11.5	3.2	20.2	7.7	3.8	4.7	1.6	5.6	8.9	4.0	2.4	2.0	2.9	9.9	5.2	1.1	3.0	5.7	0.6	3.2	1.0	0.4	1.4	1.4	1.1	0.1	1.6	0.8	1.0	1.7	4.2	0.7	1.6	1.1	15.9	33.1	18.2	31.2	15.8	13.6	9.1	12.6	11.7	9.1
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85606654-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"				"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: "	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	10.7	9.8	7.0	17.4	12.3	11.5	16.5	16.6	9.9	16.5	15.2	17.2	17.7	13.1	17.1	15.0	13.6	14.3	16.2	13.7	7.7	6.6	13.5	16.8	17.5	15.6	16.1	7.2	22.2	25.4	13.3	14.6	21.8	11.4	16.5	14.1	10.8	20.6	20.6	23.3	18.6	18.5	14.8	10.9	17.5	13.4	15.1	12.3	37.1	17.2	20.4	17.6	15.2	17.0	15.4	16.5	36.1	22.7	19.2	20.1	9.5	8.5	8.0	13.1	9.9	13.5	6.7	8.9	3.9	5.2	6.5	8.8	7.1	10.4	11.6	6.0	7.2	9.5	7.2	7.9	7.1	6.1	15.0	19.9	11.7	7.4	11.1	10.7	10.5	10.2	9.1	4.9	13.1	10.7	10.0	13.1	6.3	9.7	12.1	10.4	6.2	6.9	13.6	25.0	11.4	8.4	9.1	16.8	12.1	6.1	8.1	7.9	9.2	5.4	6.3	4.7	13.1	5.3	3.7	16.9	11.8	10.8	7.0	10.8	5.7	18.0	22.7	36.1	15.4	15.0	14.5	10.9	14.7	14.5	16.5	15.4	20.1	18.7	36.1	19.2	16.9	10.6	11.9	9.5	7.0	12.3	16.6	9.9	7.7	6.6	16.1	7.2	11.4	12.3
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: , HPA052175: "	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.3	6.5	15.4	10.7	6.0	8.6	6.7	5.9	9.7	6.0	8.7	4.7	13.2	8.8	4.9	12.4	8.7	6.1	4.4	5.1	12.5	4.9	5.8	9.1	12.6	11.7	15.9	6.9	9.3	5.8	6.1	10.5	12.9	10.1	5.7	18.7	10.2	24.3	13.0	12.5	20.9	5.2	11.2	6.3	9.8	8.6	15.9	6.5	21.6	9.0	9.8	17.7	7.5	8.1	26.5	8.8	14.6	12.3	12.0	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: , HPA065070: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.0	17.3	21.0	14.9	1.1	2.3	19.1	27.3	8.2	23.9	29.0	19.6	11.2	20.2	17.1	5.8	36.4	18.1	12.4	23.8	10.7	14.2	16.4	20.7	17.6	0.7	22.4	10.1	0.5	0.9	27.7	16.7	7.2	29.9	19.0	11.6	13.1	32.5	5.4	17.2	6.4	24.0	51.0	19.1	4.0	28.2	14.4	12.9	24.8	85.2	8.4	17.3	19.4	6.0	17.3	24.7	28.3	32.3	7.9	17.2	39.0	15.0	14.8	18.9	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2
CDH24	CDH11L	ENSG00000139880	"Cadherin 24"	Q86UP0	14	23047062-23057538	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065233			Approved	"Nucleoplasm,Cell Junctions,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite"	"Cell Junctions, Cytosol"	"HPA065233: "	"unprognostic (2.30e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.71e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.97e-2)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.85e-2)"	5.8	4.7	8.0	4.3	9.3	2.9	5.0	13.0	12.6	6.2	4.5	4.0	6.1	3.0	13.4	3.2	5.8	5.8	10.1	3.8	10.5	5.1	4.6	1.1	4.7	3.4	4.4	4.8	3.8	3.5	8.3	3.1	5.7	5.3	4.6	4.5	7.9	4.7	4.5	1.8	7.2	5.0	10.2	4.0	5.2	4.1	3.4	6.6	7.8	6.8	3.8	4.1	7.3	6.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.5	2.5	10.6	12.0	2.6	1.3	5.9	4.8	3.1	4.0	5.2	3.2	3.5	0.2	3.9	5.2	14.6	4.5	4.0	3.3	3.9	3.8	0.5	6.5	1.0	2.9	7.3	0.2	10.2	1.3	4.4	2.9	6.6	1.5	6.3	3.5	7.2	0.5	4.9	2.6	5.9	12.7	3.5	4.7	1.1	2.1	30.8	8.2	11.2	6.0	0.6	5.3	1.0	6.1	4.0	15.5	1.6	3.5	2.0	0.6	0.1	4.2	2.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	9.3	13.0	12.6	10.5	5.1	4.4	4.8	5.3	6.6
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 125.1;LHCN-M2: 138.1;RH-30: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: "	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.3	10.8	14.3	12.7	13.1	11.5	9.5	5.4	17.6	23.8	19.8	15.4	8.9	13.6	9.7	8.4	7.2	19.7	125.1	18.1	6.7	9.1	12.7	7.3	10.8	15.4	14.4	8.8	11.3	9.2	14.6	16.8	15.3	13.5	11.7	138.1	13.5	13.7	11.7	16.8	11.0	12.4	434.6	12.6	7.4	14.7	12.9	12.1	9.5	7.2	14.4	9.6	17.5	6.9	11.2	10.5	12.6	10.9	5.8	9.5	20.9	10.3	13.3	13.4	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506588-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023654, HPA052426, HPA052428, HPA061371"	Approved		Approved	"Nucleoplasm,Vesicles,Mitotic spindle,Centrosome"				Nucleoplasm	"Vesicles, Mitotic spindle, Centrosome"	"HPA023654: AB_2072077, HPA052426: , HPA052428: , HPA061371: "	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favourable (5.78e-4)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	13.0	8.6	10.9	17.1	13.1	37.9	15.5	27.9	15.6	16.7	14.2	16.2	11.6	11.9	26.5	16.6	10.7	17.1	12.3	10.6	11.5	7.8	14.1	11.7	13.0	20.7	13.6	7.9	27.3	15.5	11.8	20.4	8.5	13.0	15.2	13.5	15.6	13.8	19.8	14.6	21.7	14.2	15.0	17.4	13.2	13.3	16.9	13.9	26.4	21.0	8.6	14.7	14.3	14.0	5.9	3.7	2.2	3.6	2.1	10.8	2.4	10.0	6.4	13.1	11.3	3.5	9.0	13.1	5.1	5.2	6.4	9.7	7.7	5.8	16.1	3.4	7.2	12.8	11.2	9.9	13.2	4.2	8.6	14.3	12.4	14.8	11.6	15.5	7.7	10.2	10.4	7.1	15.9	5.4	16.4	11.8	7.0	11.8	19.6	9.9	8.1	8.0	14.1	23.7	11.9	7.4	16.1	8.3	15.0	7.0	10.3	13.3	11.4	10.4	8.0	14.6	11.4	6.7	6.9	12.0	9.6	17.1	6.3	11.9	8.9	2.2	3.6	2.2	4.5	2.9	10.8	4.5	5.2	4.5	3.4	5.9	8.0	5.4	1.4	2.1	3.4	3.7	4.2	2.4	10.9	13.1	27.9	15.6	11.5	7.8	13.6	7.9	13.0	13.9
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116104-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 79.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favourable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	35.4	17.6	13.7	29.8	17.4	66.8	31.6	26.9	12.6	20.5	25.7	13.5	31.3	17.5	24.7	27.6	21.0	19.2	22.1	58.1	14.7	7.7	24.9	18.9	58.5	34.3	16.8	8.9	14.6	14.3	9.1	18.7	28.3	12.6	23.2	17.7	20.9	21.8	27.4	113.7	16.7	26.8	30.5	13.8	35.7	19.4	10.9	14.8	17.2	31.2	26.2	31.4	24.1	33.7	5.3	6.6	79.2	12.6	8.7	11.8	7.8	5.1	10.6	7.6	4.5	23.6	18.1	9.4	13.1	22.9	8.7	10.6	12.2	19.4	1.4	12.5	15.2	3.8	2.4	9.9	13.9	38.8	7.4	7.8	9.1	19.8	16.5	5.8	25.9	19.7	9.8	14.6	12.9	44.0	26.3	32.7	15.7	4.3	2.7	23.2	2.6	8.0	2.8	1.8	11.1	10.8	10.7	1.7	3.0	8.8	7.8	10.3	5.5	10.9	47.7	18.2	7.6	6.7	6.4	54.5	17.9	8.7	12.9	4.7	9.0	16.3	12.1	13.5	11.7	12.3	10.3	5.3	10.1	11.0	6.6	4.0	6.4	8.3	79.2	8.7	12.6	4.6	11.8	7.8	13.7	17.4	26.9	12.6	14.7	7.7	16.8	8.9	12.6	14.8
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979249	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: , HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavourable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.37e-1)"	25.3	14.5	13.5	13.4	19.0	36.4	24.8	4.2	14.6	15.6	17.4	12.4	19.8	14.7	14.7	13.8	28.2	15.2	14.1	16.5	15.3	8.0	16.6	29.5	12.9	23.8	29.5	8.8	14.2	12.8	8.3	9.4	35.6	15.9	11.7	18.8	7.5	12.8	13.1	5.9	22.6	22.9	12.5	19.8	18.0	14.7	22.8	21.5	30.2	15.5	19.3	25.5	11.1	23.3	23.9	30.4	2.2	32.8	9.0	12.2	8.7	59.4	82.1	61.5	33.3	8.9	9.1	49.2	27.7	21.5	60.1	48.2	79.3	88.0	56.7	47.4	18.3	55.2	61.0	39.7	56.5	50.9	39.5	38.3	36.5	55.7	2.7	46.1	35.3	5.3	17.2	51.4	71.3	30.1	62.2	77.1	45.2	59.2	43.2	35.6	78.0	74.1	43.5	50.7	72.6	21.4	21.8	25.1	63.4	41.9	39.7	45.8	53.1	64.6	16.8	39.1	40.5	32.2	65.9	47.6	92.3	80.0	24.8	39.3	53.9	0.7	4.4	2.2	7.0	26.0	8.4	23.9	9.9	9.5	7.2	22.6	12.2	11.5	0.6	9.0	32.8	30.4	10.6	8.7	13.5	19.0	4.2	14.6	15.3	8.0	29.5	8.8	15.9	21.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: , HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	86.6	74.3	45.5	30.4	13.4	12.2	33.2	51.6	27.9	57.2	45.8	30.5	43.0	64.9	30.6	19.3	61.0	54.5	39.7	65.8	50.6	44.1	32.9	54.4	80.9	5.8	67.0	37.5	4.4	9.2	40.9	36.2	52.9	39.2	56.9	73.2	65.0	52.6	118.1	66.4	68.6	45.6	50.0	38.7	44.9	19.9	38.5	22.9	42.8	41.6	41.6	50.1	39.0	30.0	24.7	47.0	59.7	75.0	46.1	93.5	52.4	36.5	38.8	35.2	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog (yeast)"	Q9BQ75	3	99817834-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"				Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavourable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	21.4	34.1	23.7	15.1	24.5	17.7	20.6	24.1	27.4	13.4	12.9	9.4	8.2	8.3	19.6	10.7	12.0	13.3	10.5	16.6	24.0	22.2	17.1	17.5	10.8	15.8	15.3	22.3	21.1	26.4	20.7	25.9	11.7	19.2	15.1	12.4	9.3	12.4	14.5	58.2	11.5	9.3	13.8	15.7	12.9	11.0	28.1	13.5	13.6	14.9	14.4	14.7	18.8	15.7	23.5	26.1	1.6	10.9	11.2	19.0	7.9	28.5	12.9	12.8	18.4	9.1	10.7	13.2	13.3	7.2	24.0	20.0	16.0	9.6	30.9	23.4	7.1	17.3	17.7	15.1	31.7	16.0	16.9	24.4	9.2	13.0	16.3	33.3	13.4	7.3	14.7	17.9	29.9	16.5	15.0	20.1	17.3	19.7	26.6	31.1	18.7	32.5	12.0	20.7	33.1	14.8	7.0	36.1	15.2	13.3	10.9	30.3	13.1	20.8	4.7	19.0	54.0	11.0	27.0	14.4	28.6	60.1	12.3	36.9	31.7	0.3	4.7	0.8	10.0	10.9	14.2	23.2	14.8	13.5	9.9	23.5	18.7	19.0	1.6	11.2	9.7	26.1	13.7	7.9	23.7	24.5	24.1	27.4	24.0	22.2	15.3	22.3	19.2	13.5
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536630	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: "	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	12.5	17.4	8.7	17.1	14.0	10.9	17.0	19.7	14.5	16.9	17.1	13.0	22.4	13.2	16.9	20.6	14.4	14.0	12.8	12.5	8.9	9.4	16.5	46.2	12.1	11.7	9.3	10.0	17.9	29.4	10.9	22.6	32.9	11.5	20.9	20.7	12.9	28.3	25.2	12.5	14.7	18.8	13.3	10.1	14.8	15.6	9.9	11.2	17.4	18.5	8.7	18.5	14.8	14.8	5.1	7.2	7.4	4.6	4.9	8.0	3.8	5.8	5.3	10.2	9.1	13.4	15.4	9.7	9.7	13.8	11.4	9.5	7.7	10.8	8.0	4.3	11.5	12.8	8.4	9.8	17.3	6.2	6.8	9.0	6.4	13.5	16.6	13.1	8.6	11.5	14.9	7.5	26.8	11.0	5.8	4.9	13.5	9.0	7.2	12.4	8.3	6.4	8.5	5.9	7.4	10.6	9.5	5.1	9.2	6.3	12.4	12.9	8.5	13.6	10.3	5.5	4.3	10.2	6.1	6.9	3.7	8.3	10.5	6.7	9.7	7.4	4.1	7.3	7.5	4.6	8.0	5.1	5.8	6.4	3.1	4.9	6.6	6.1	3.7	4.9	2.9	7.2	6.2	3.8	8.7	14.0	19.7	14.5	8.9	9.4	9.3	10.0	11.5	11.2
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: , HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				8.5	12.4	4.5	6.6	9.1	2.8	6.9	5.1	8.5	9.7	11.9	4.7	8.3	4.9	4.0	5.9	9.4	8.3	4.3	14.3	4.7	4.1	5.5	6.9	8.0	5.0	6.6	4.7	4.3	11.4	5.7	8.7	4.7	5.7	5.0	2.8	4.2	8.3	14.6	22.8	4.8	7.6	7.0	7.3	7.3	7.6	23.4	6.6	12.3	3.7	7.6	6.4	12.0	5.4	25.0	30.3	25.7	25.8	18.8	21.6	26.6	3.8	13.8	4.8	0.5	5.6	3.8	0.7	3.9	4.3	2.1	5.5	7.6	1.5	1.9	5.7	13.0	1.8	5.1	8.4	0.7	15.2	1.7	5.2	2.9	3.3	17.1	0.4	2.4	6.7	4.8	7.6	4.0	5.3	1.0	5.4	0.6	3.7	15.6	0.5	0.5	4.3	4.4	5.3	4.2	2.1	4.7	0.5	1.7	7.4	1.8	1.6	3.4	3.8	7.0	1.7	5.4	0.3	1.0	11.6	14.0	6.1	2.6	11.6	1.7	25.7	25.8	17.2	15.1	23.5	16.6	25.0	16.1	14.7	30.3	21.9	11.0	12.2	3.8	18.8	17.8	29.2	21.6	26.6	4.5	9.1	5.1	8.5	4.7	4.1	6.6	4.7	5.7	6.6
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.3	12.1	8.4	10.9	32.4	25.3	6.9	16.5	24.6	13.8	15.7	7.8	11.8	9.4	11.0	20.1	26.6	18.0	17.6	24.9	10.0	14.1	1.5	8.9	9.3	11.2	0.8	0.8	17.1	19.0	15.3	20.4	16.9	8.4	18.2	17.1	13.3	16.5	0.5	3.2	17.6	7.9	7.7	44.0	17.9	24.7	17.8	14.0	14.4	66.0	10.4	25.1	2.6	18.0	12.4	12.1	16.4	12.8	13.0	15.6	2.6	17.8	3.5	11.4	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683677-18782333	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022035	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255"	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favourable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.6	7.7	26.0	7.4	38.8	3.2	3.8	40.7	30.1	5.0	4.4	6.5	4.3	6.5	6.8	5.6	3.1	10.5	5.5	5.6	17.7	7.8	6.6	4.5	5.7	6.3	6.4	18.1	6.7	10.0	8.4	11.3	6.4	6.0	7.0	2.6	5.1	8.8	9.4	12.4	5.5	6.2	4.3	4.8	8.1	8.0	7.5	10.2	1.9	7.4	1.1	3.7	4.6	3.5	4.1	3.8	1.8	3.4	1.1	3.0	1.3	4.3	8.0	5.8	9.3	5.4	4.6	16.5	4.8	3.2	4.6	4.5	5.4	5.7	6.1	10.2	4.6	4.7	1.7	3.0	1.1	2.7	13.9	5.1	7.1	8.8	5.2	7.0	14.5	7.4	2.9	4.0	1.2	2.6	4.0	5.6	2.6	16.0	4.5	8.1	7.5	11.8	7.2	2.5	6.7	2.9	7.8	10.7	9.6	5.4	5.2	5.8	5.8	4.3	4.6	5.3	8.1	9.6	5.5	3.8	3.0	4.0	6.1	7.6	4.0	1.5	3.4	1.8	1.7	1.3	1.8	2.3	2.7	3.0	3.0	4.1	2.3	1.8	1.7	1.1	1.9	3.8	1.8	1.3	26.0	38.8	40.7	30.1	17.7	7.8	6.4	18.1	6.0	10.2
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"			210000	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.4	3.0	2.6	19.0	14.5	16.8	2.6	4.9	8.8	2.1	1.7	1.1	3.2	0.0	9.3	6.7	0.8	2.5	4.4	2.2	8.3	2.1	6.1	0.3	23.7	8.3	1.9	5.5	9.9	2.8	1.6	10.0	23.0	0.4	2.4	5.6	12.5	5.2	3.1	0.1	4.6	2.7	1.7	0.4	18.3	7.4	1.8	2.2	2.9	1.4	21.8	9.4	7.8	22.0	2.7	1.2	6.5	3.0	3.4	0.7	0.0	5.1	3.4	10.9	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell line enriched"	"Detected in many"	8	"BEWO: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavourable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	7.3	2.2	2.5	6.5	0.1	0.0	113.4	0.0	0.0	1.6	1.3	14.9	7.3	0.1	0.6	0.1	14.0	12.1	8.9	2.3	0.0	1.6	0.3	0.7	2.3	0.0	0.0	1.0	0.0	3.0	0.4	0.3	0.5	0.2	0.0	2.9	2.7	0.2	0.1	15.0	2.1	0.0	5.4	0.1	2.2	0.9	0.6	1.1	7.4	2.6	2.6	4.6	0.8	0.0	0.4	7.4	0.1	0.8	1.5	4.0	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"				"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	14.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.2	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7
CYB561A3	CYBASC3	ENSG00000162144	"Cytochrome b561 family member A3"	Q8NBI2	11	61348745-61362299	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.7;blood: 98.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8"	"Group enriched"	"Detected in all"	10	"B-cells: 50.1;dendritic cells: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045674, HPA052548"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				"Nucleoli, Vesicles"	"Nucleoplasm, Cytosol"	"HPA045674: , HPA052548: AB_2681866"	"unprognostic (2.61e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.41e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.80e-3)"	10.0	113.7	4.0	22.5	6.4	7.1	7.5	4.7	6.9	6.6	10.9	10.9	14.4	6.1	10.9	9.9	8.8	11.0	11.0	5.7	5.1	4.1	9.7	30.6	12.4	21.7	8.3	3.5	14.5	17.9	9.0	6.6	21.0	6.8	9.2	9.6	10.7	10.9	8.1	10.2	24.8	15.8	7.6	5.6	24.0	8.5	8.0	7.0	16.8	10.0	8.4	33.3	10.7	7.3	50.1	98.8	3.8	7.4	3.3	3.8	8.7	18.0	30.5	4.9	14.1	23.2	15.4	4.1	9.1	13.9	11.0	11.0	8.3	20.2	35.2	16.4	16.0	25.3	4.6	25.4	6.7	23.5	10.4	6.0	20.6	5.6	10.9	8.3	15.8	21.6	35.9	23.9	11.0	16.3	19.8	21.1	18.5	19.4	15.7	3.6	9.1	17.5	19.0	4.7	26.3	12.7	17.9	6.0	10.0	18.6	26.9	21.0	21.8	9.7	10.9	13.0	6.7	12.6	13.1	13.2	17.4	19.7	17.8	14.6	16.3	1.6	7.4	3.8	3.8	6.0	3.4	40.5	2.7	3.4	7.4	50.1	2.8	3.0	2.5	3.3	6.4	98.8	2.6	8.7	4.0	6.4	4.7	6.9	5.1	4.1	8.3	3.5	6.8	7.0
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell line enhanced"	"Detected in all"		"PC-3: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"			110000	Mitochondria	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.4	13.4	28.0	11.1	12.3	25.8	12.8	15.6	32.7	21.5	35.2	27.8	31.5	28.9	17.1	33.0	29.2	25.4	12.3	19.3	38.7	33.8	42.5	32.2	19.9	19.9	22.1	17.9	31.8	20.8	41.3	18.9	30.7	28.2	17.0	79.8	37.3	18.5	15.5	151.2	33.0	17.9	55.2	26.8	35.8	36.0	15.9	35.7	49.4	26.2	40.6	30.6	14.4	20.8	44.4	23.0	38.9	31.3	22.7	23.4	26.5	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5
CYP20A1	CYP-M	ENSG00000119004	"Cytochrome P450 family 20 subfamily A member 1"	Q6UW02	2	203238940-203305611	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055872, HPA058461"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments"				"Plasma membrane, Cell Junctions, Actin filaments"	Nucleoplasm	"HPA055872: , HPA058461: "	"unprognostic (4.72e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.64e-3)"	"unprognostic (9.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-3)"	11.1	14.9	5.0	9.1	6.4	2.8	7.6	6.8	6.1	9.3	8.6	8.6	9.2	6.0	10.8	7.1	8.0	8.0	9.1	7.0	4.5	4.8	13.5	12.5	8.4	7.8	8.1	2.1	13.4	17.3	9.1	13.6	9.4	6.5	9.0	7.8	10.9	9.8	8.8	5.3	6.3	10.5	9.0	6.5	10.1	8.8	10.8	8.1	13.8	16.9	4.3	9.1	7.7	9.7	13.0	13.6	6.8	11.3	8.8	15.5	9.1	5.2	4.8	2.5	4.8	14.4	3.0	5.1	8.8	4.5	3.7	3.9	13.9	7.5	3.8	7.2	5.5	5.7	3.2	4.0	5.2	5.0	3.7	8.1	3.1	6.4	11.2	8.8	5.1	6.8	3.1	6.0	6.3	7.4	12.5	12.9	6.8	7.0	7.4	4.7	9.5	10.7	5.0	5.6	7.3	4.4	10.3	3.7	5.0	0.3	4.6	7.2	2.8	4.8	8.4	12.2	4.7	6.0	5.5	8.8	9.5	4.6	7.5	3.5	5.6	5.2	10.4	6.8	14.4	11.3	15.5	11.1	14.9	12.7	7.8	13.0	12.5	9.2	2.2	8.8	10.5	13.6	13.4	9.1	5.0	6.4	6.8	6.1	4.5	4.8	8.1	2.1	6.5	8.1
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavourable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	27.5	24.8	23.2	23.6	16.9	19.6	17.4	20.6	15.8	19.6	20.1	24.4	27.0	38.4	35.3	21.5	20.8	31.4	26.3	38.0	36.6	22.3	53.1	14.9	27.7	19.3	21.7	22.9	15.9	18.2	28.8	48.0	27.2	35.6	16.9	29.8	22.5	41.1	22.8	35.5	38.8	26.8	28.2	39.6	28.5	23.1	29.6	28.1	12.9	20.2	23.3	31.1	14.9	17.8	20.0	32.1	25.7	27.5	18.7	32.5	54.3	26.9	47.5	25.5	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0
DET1	FLJ10103	ENSG00000140543	"DET1, COP1 ubiquitin ligase partner"	Q7L5Y6	15	88494440-88546675	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Microtubules"	"Cytokinetic bridge, Cytosol"	"HPA048873: "	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	6.0	9.3	5.5	4.3	7.0	1.9	6.4	5.5	6.8	9.5	6.3	8.2	7.0	5.5	15.9	9.1	3.8	9.6	7.8	8.8	4.3	4.2	5.4	4.5	4.3	4.2	5.0	6.1	17.9	10.1	7.1	6.4	5.6	5.9	8.5	5.6	12.6	6.7	7.4	13.8	4.4	5.9	11.4	5.1	4.4	5.5	3.6	4.6	10.7	6.8	4.1	6.4	7.7	6.0	5.3	7.6	2.9	7.4	3.4	6.6	3.8	2.0	6.7	9.5	6.9	4.7	7.1	1.8	6.5	7.0	5.7	6.0	1.4	6.3	3.9	5.0	8.3	3.1	10.7	2.0	4.9	0.3	6.9	7.4	3.7	2.3	7.4	2.8	1.5	6.1	7.2	2.7	7.8	4.4	9.4	4.7	7.1	3.2	4.0	3.1	4.3	2.1	4.7	7.8	4.8	3.0	5.9	3.7	5.8	7.3	2.5	16.2	3.6	5.9	3.6	5.8	4.5	5.9	6.0	2.7	1.9	2.6	6.5	4.8	5.1	0.0	4.8	2.9	5.3	7.4	3.9	4.8	4.6	4.7	7.6	5.3	6.6	5.4	0.7	3.4	4.6	4.1	5.1	3.8	5.5	7.0	5.5	6.8	4.3	4.2	5.0	6.1	5.9	4.6
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	8.2	11.4	24.1	9.6	21.9	3.9	13.7	8.6	19.8	17.8	10.1	8.5	19.7	7.3	9.8	15.0	12.3	33.5	12.7	9.9	17.7	15.2	16.0	7.1	12.8	7.5	9.5	15.7	15.8	14.9	19.2	19.3	11.9	7.9	13.2	9.2	13.1	16.4	16.3	4.4	11.4	8.0	7.7	6.4	7.5	11.1	36.5	9.7	13.2	26.1	6.6	8.6	8.4	9.1	12.6	14.8	17.5	11.2	15.7	16.6	8.1	8.8	4.5	9.1	8.1	11.6	11.7	0.0	3.7	7.3	5.8	6.4	2.8	10.5	2.2	8.2	5.5	4.3	5.7	10.1	4.1	5.5	7.4	1.2	1.3	3.1	18.5	7.1	1.9	9.4	33.0	7.8	14.1	8.4	2.6	4.5	7.2	11.0	6.6	7.0	3.5	3.6	6.4	3.9	2.9	12.3	5.3	12.8	6.9	7.8	6.0	15.3	10.9	6.8	5.1	5.3	5.4	8.1	3.8	2.8	0.8	1.0	16.0	2.4	5.1	15.6	9.6	12.8	13.5	9.5	16.6	8.7	11.2	12.1	9.8	12.6	13.3	11.0	17.5	15.7	11.2	14.8	10.2	8.1	24.1	21.9	8.6	19.8	17.7	15.2	9.5	15.7	7.9	9.7
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.0;HL-60: 16.8;MOLT-4: 15.7;NB-4: 26.6;REH: 19.8;RT4: 17.5;THP-1: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003218	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol				Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695"	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favourable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favourable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.4	17.0	1.2	0.0	0.7	0.2	0.1	0.0	5.8	0.6	0.0	0.0	0.0	0.0	16.8	2.3	0.0	3.1	0.0	0.0	0.0	3.7	8.6	0.0	1.0	15.7	26.6	0.0	0.2	19.8	0.0	6.5	0.0	17.5	0.0	0.0	0.0	0.2	1.1	0.4	50.6	3.3	0.0	0.1	0.2	0.0	3.4	0.0	0.0	0.0	10.6	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 homolog, MIS12 kinetochore complex component"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Cytosol"	"HPA002813: AB_1078343, HPA030627: "	"unprognostic (3.60e-2)"	"prognostic favourable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	6.7	10.4	5.6	15.6	7.4	11.6	8.2	5.4	7.2	5.1	8.6	4.1	9.5	6.3	9.5	12.0	9.1	5.0	8.1	6.2	5.1	4.7	5.8	8.6	6.1	11.0	4.8	3.9	5.3	5.4	3.6	7.6	12.9	5.1	6.5	10.3	10.1	9.7	8.1	4.6	7.3	8.8	5.9	4.1	11.6	7.0	27.2	4.1	21.2	6.3	11.4	13.8	5.8	5.5	10.9	25.4	21.7	5.9	5.6	6.5	3.7	13.1	11.9	14.0	11.1	5.5	7.2	9.2	16.1	13.6	24.7	27.9	20.6	17.0	15.1	10.7	8.7	17.3	13.0	12.6	23.6	6.7	8.3	29.5	11.4	13.8	1.2	16.9	13.0	2.8	3.6	17.1	5.4	12.0	11.5	12.6	16.2	9.4	21.6	13.0	6.5	21.0	17.0	42.6	10.1	6.2	7.8	14.3	6.5	20.0	20.6	9.7	21.0	11.4	6.3	22.6	13.8	22.1	17.3	10.6	14.2	17.2	19.0	15.3	16.1	21.7	3.6	7.5	4.4	5.9	4.9	8.8	4.8	5.8	3.9	10.9	5.9	5.5	6.5	5.6	5.0	25.4	6.5	3.7	5.6	7.4	5.4	7.2	5.1	4.7	4.8	3.9	5.1	4.1
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;U-2 OS: 3.6;U-266/70: 7.8;U-266/84: 10.1;U-698: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: "																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.4	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	3.6	0.7	0.0	7.8	10.1	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427355-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytokinetic bridge"				"Nucleoplasm, Nuclear bodies, Vesicles"	"Cytokinetic bridge"	"HPA059516: , HPA060569: , HPA069538: "	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	15.6	11.5	13.9	12.2	20.0	55.7	11.4	18.1	19.1	9.8	11.7	13.3	11.5	12.7	10.1	9.9	13.1	9.4	12.9	7.6	14.3	18.1	13.7	22.2	12.0	12.4	14.7	13.0	8.0	11.8	13.0	17.6	18.9	18.6	12.7	12.4	9.6	9.5	15.4	8.6	15.9	12.5	10.4	13.7	15.1	13.7	9.7	10.1	14.0	13.0	9.1	12.9	11.9	9.0	5.1	9.9	7.1	7.4	8.1	15.4	4.3	3.9	6.4	6.8	7.0	4.0	3.4	55.0	5.8	4.1	6.7	6.5	8.8	4.4	11.0	3.7	4.2	3.3	8.9	5.1	7.7	9.0	6.4	9.5	5.8	8.0	9.0	8.9	7.7	4.5	9.1	9.6	6.5	6.6	10.1	8.2	5.5	8.1	8.8	5.0	12.2	6.7	8.1	5.6	6.1	5.8	6.9	7.0	12.3	7.1	6.6	6.7	9.9	7.1	6.4	7.0	5.2	6.2	8.3	10.8	21.6	11.6	6.8	10.7	8.3	7.1	7.4	4.5	12.0	5.4	15.4	5.1	10.1	9.3	4.3	3.8	6.0	9.8	6.7	8.1	6.5	9.9	10.5	4.3	13.9	20.0	18.1	19.1	14.3	18.1	14.7	13.0	18.6	10.1
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	4.3	8.4	12.7	3.5	16.7	3.1	9.3	24.5	19.5	9.4	5.1	3.7	6.4	3.2	9.6	9.8	5.7	12.6	7.2	9.7	11.4	11.8	8.8	2.8	6.2	5.2	8.1	10.8	12.8	4.9	16.3	31.6	5.1	13.7	8.7	5.0	3.5	5.3	8.2	10.8	4.9	3.4	7.5	9.4	4.2	5.0	20.0	10.2	11.5	9.1	2.4	5.2	7.3	12.9	3.3	1.7	9.8	3.3	1.8	2.9	1.1	6.2	5.2	6.9	4.4	7.3	10.9	3.5	4.1	4.4	7.0	8.7	1.7	4.9	4.4	9.7	2.3	5.8	5.9	3.9	8.4	8.1	4.1	3.5	9.8	3.6	4.7	4.9	3.2	5.9	9.5	8.2	5.6	5.9	4.4	7.2	4.6	1.3	9.3	3.3	3.0	5.3	6.0	10.4	4.3	10.8	3.4	14.8	5.7	7.7	4.4	9.9	4.5	3.5	1.6	3.9	3.5	11.7	3.8	4.8	8.3	5.1	7.3	3.5	5.8	9.8	0.7	0.2	2.1	0.4	2.9	3.3	2.4	2.5	1.3	2.8	2.5	2.4	0.1	1.8	3.3	1.7	2.7	1.1	12.7	16.7	24.5	19.5	11.4	11.8	8.1	10.8	13.7	10.2
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"U-698: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol			22000	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: "	"unprognostic (6.27e-2)"	"prognostic favourable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	30.3	26.4	48.9	26.9	48.9	46.8	33.0	33.8	69.3	31.7	31.8	28.0	26.8	34.4	29.7	45.4	66.3	26.3	28.5	30.0	42.4	37.9	31.7	32.3	28.6	30.0	42.0	39.0	27.7	30.5	33.0	25.2	37.5	34.6	23.9	30.4	28.5	29.4	22.8	67.7	49.8	34.0	27.3	38.3	23.8	28.7	12.8	27.3	25.8	35.2	42.9	35.5	31.7	36.3	34.4	39.5	49.5	33.6	33.0	33.2	38.4	14.3	7.6	10.5	10.1	6.7	5.6	11.4	6.5	6.6	9.7	8.2	8.5	10.9	12.9	10.8	5.2	11.6	8.5	14.4	7.2	22.3	11.9	18.5	10.7	6.4	4.5	14.9	23.9	4.4	8.9	10.0	12.8	9.1	14.1	27.2	6.5	31.1	14.6	12.1	21.1	9.3	14.3	8.7	16.1	12.7	12.6	15.8	10.0	9.2	19.4	10.0	26.5	21.9	9.6	7.2	13.4	8.6	16.7	15.3	22.2	419.6	10.0	17.3	9.5	28.7	30.7	49.5	32.2	33.6	28.9	34.4	27.0	33.2	39.5	31.8	22.3	32.9	29.0	33.0	31.9	30.2	29.8	38.4	48.9	48.9	33.8	69.3	42.4	37.9	42.0	39.0	34.6	27.3
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Cell line enriched"	"Detected in some"	6	"AF22: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305572-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053785			Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"				"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	8.2	9.6	6.0	8.9	7.7	7.9	17.8	9.8	9.4	4.3	32.4	4.9	18.3	43.1	4.6	6.2	17.1	4.1	15.7	45.2	6.8	5.0	21.4	26.9	8.7	9.2	10.4	5.2	2.5	20.5	10.1	4.6	11.0	8.0	7.5	12.6	6.0	28.7	14.9	78.3	10.5	46.4	7.1	7.4	9.3	14.1	2.2	6.0	6.0	8.2	27.1	10.0	8.5	12.0	4.1	4.2	8.5	8.4	2.6	5.4	2.4	9.7	15.6	3.9	9.4	5.3	5.1	21.2	9.6	4.7	3.6	3.6	14.4	11.9	13.4	18.0	5.1	25.1	6.5	12.9	1.4	9.0	8.4	8.6	18.5	11.3	7.3	14.6	21.8	7.2	19.7	8.1	10.7	5.0	14.5	7.4	5.9	21.9	7.1	20.8	10.8	29.7	7.7	7.6	29.9	12.0	20.6	8.2	10.1	4.9	32.7	30.9	10.1	14.5	10.8	6.6	7.9	18.5	9.7	11.4	9.4	8.8	10.7	14.4	5.2	0.3	4.7	7.1	4.4	8.4	4.4	2.9	3.8	3.1	4.2	4.1	4.1	5.4	8.5	2.6	7.5	3.2	5.1	2.4	6.0	7.7	9.8	9.4	6.8	5.0	10.4	5.2	8.0	6.0
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"	Q2M3D2	19	45212621-45245431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 17.8;K-562: 16.4"									"Group enriched"	"Detected in some"	4	"basophil: 1.6;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.5"									"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: "																		3.2	4.3	0.0	2.0	0.0	0.9	3.0	0.0	0.3	3.6	2.1	0.1	2.4	2.3	14.5	1.2	2.3	0.6	6.9	1.9	0.0		12.7	9.4	3.4	6.3	0.0	0.0	3.4	2.8	2.4	3.5	0.4	0.0	3.7	0.2	13.7	3.3	3.6	1.0	2.4	3.9	1.6	0.0	12.6	2.4	2.1	0.0	0.0	4.6	1.5	3.2	1.6	3.3	0.5	0.3	2.5	0.4	0.2	0.4	0.2	0.1	0.3	2.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	2.1	0.0	1.1	0.0	0.1	0.0	0.1	0.0	17.8	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.4	0.3	0.0	0.2	0.0	0.0	0.2	0.5	1.2	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.4	0.8	1.6	0.3	0.1	0.2	0.1	0.0	0.1	0.2	0.1	1.6	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	2.5	0.2	0.3	0.3	0.1	0.2										
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109714228-109770507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.9"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA058774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria"				"Nucleoplasm, Plasma membrane"	"Focal adhesion sites, Mitochondria"	"HPA040181: AB_10796448, HPA058774: "	"unprognostic (8.59e-3)"	"prognostic favourable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favourable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favourable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	1.8	16.0	7.3	2.3	17.4	2.0	3.0	15.1	25.5	1.6	3.3	37.9	0.0	10.0	1.5	2.7	2.1	1.4	2.6	4.4	11.7	9.6	7.7	2.7	1.8	1.7	23.2	7.9	7.8	6.9	1.5	13.1	1.3	15.1	2.3	3.0	10.3	7.3	2.1	2.8	4.7	5.1	1.8	27.8	6.3	8.0	17.4	23.0	0.0	1.4	0.0	2.1	1.4	2.4	0.2	0.6	0.9	0.2	0.0	0.2	0.0	0.8	1.3	0.7	1.6	0.4	0.0	0.5	0.2	0.1	0.7	0.1	11.7	0.2	0.1	1.0	0.3	0.5	0.8	0.0	0.2	7.5	1.7	1.4	0.3	2.6	0.1	1.1	1.5	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	4.7	0.3	1.5	1.3	2.3	0.9	3.4	0.5	1.5	0.6	8.3	50.2	1.0	1.6	3.3	1.9	1.2	0.1	0.2	1.4	0.6	1.0	1.3	1.6	1.0	0.1	0.8	1.6	0.0	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	7.3	17.4	15.1	13.7	11.7	9.6	23.2	7.9	15.1	23.0
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: "	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.5	9.1	17.5	4.9	0.9	1.3	45.3	7.9	3.5	11.4	9.3	6.8	8.5	16.8	3.7	2.6	7.5	18.0	6.1	11.4	8.0	12.2	23.0	14.0	6.5	0.1	17.0	14.4	0.4	1.0	12.8	7.1	6.8	14.0	19.3	8.5	9.9	14.2	6.5	21.1	6.4	15.5	14.2	11.9	3.9	9.7	4.9	9.6	9.7	7.6	3.1	11.6	10.8	3.9	9.4	10.8	5.7	11.4	8.2	16.0	28.5	5.4	17.5	16.1	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;Karpas-707: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: , HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favourable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.0	2.5	15.4	6.0	0.4	0.0	0.4	0.1	0.6	2.4	4.5	2.4	3.6	4.6	5.6	0.1	4.1	1.7	2.5	2.3	1.8	2.9	2.2	0.2	1.3	0.3	2.6	1.6	0.2	8.3	0.6	2.5	0.0	0.8	17.8	1.0	4.1	0.3	3.6	3.3	3.5	0.1	3.6	7.1	3.2	2.1	10.0	4.2	0.3	2.5	6.7	10.7	4.5	0.5	1.3	4.7	2.7	2.2	3.9	3.4	3.9	5.2	0.6	2.7	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: "	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	23.2	19.3	13.8	17.7	21.2	12.6	20.6	20.8	21.1	22.3	18.4	20.0	20.4	13.8	25.2	18.2	17.6	16.7	16.9	24.1	18.8	13.8	19.2	25.7	20.7	19.0	16.3	18.8	19.2	16.9	29.2	34.1	19.7	24.6	22.2	19.3	16.4	19.4	18.7	28.5	19.3	18.4	18.2	17.8	24.8	18.8	20.0	18.9	26.9	18.1	17.1	21.7	21.7	18.0	5.5	8.1	13.7	14.8	8.0	7.9	4.9	8.4	9.0	14.1	10.3	15.9	17.9	7.4	11.1	21.3	15.9	21.8	13.3	10.5	12.4	11.0	18.0	12.0	14.7	14.0	19.2	13.5	9.4	7.3	13.3	9.0	15.9	19.8	12.1	17.3	12.0	15.2	15.0	21.3	8.1	13.4	15.5	3.4	12.4	9.3	6.6	13.8	11.2	20.6	12.3	15.4	9.9	12.6	12.3	14.8	9.9	14.3	10.5	14.4	13.9	14.5	5.3	7.6	12.3	16.5	16.6	10.6	14.5	11.3	11.0	13.7	6.3	9.0	5.9	8.6	6.3	5.5	5.5	5.7	8.1	4.8	5.7	7.2	12.0	8.0	14.8	3.9	7.9	4.9	13.8	21.2	20.8	21.1	18.8	13.8	16.3	18.8	24.6	18.9
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	54	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	8.5	7.6	9.6	2.9	13.7	2.8	5.2	5.1	11.9	6.8	5.9	5.5	3.7	2.1	3.3	5.0	2.9	4.5	4.4	10.1	8.8	4.3	7.2	7.9	4.3	2.5	8.7	4.7	14.3	7.2	1.8	12.1	4.4	7.7	4.8	3.4	4.3	8.4	9.9	3.6	3.2	3.6	5.6	9.1	8.7	4.5	4.4	10.5	0.0	3.1	3.0	1.6	4.1	6.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	5.7	2.1	17.3	0.0	0.0	0.0	6.4	2.2	1.5	1.6	3.0	0.0	2.1	0.0	6.2	2.4	0.8	5.7	2.4	1.3	0.0	4.3	0.0	4.0	4.1	1.4	0.0	0.0	0.8	2.1	3.1	8.5	3.7	0.0	0.0	4.7	1.4	0.0	0.0	7.3	2.7	0.0	5.8	0.0	4.0	1.9	2.7	2.3	0.0	1.6	1.5	1.8	0.0	0.3	7.2	6.5	0.0	4.6	1.0	0.0	0.0	2.1	0.0	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	13.7	5.1	11.9	8.8	4.3	8.7	4.7	7.7	10.5
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015984-96215612	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 37.7;stomach 1: 35.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: "	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	1.1	1.7	18.5	1.1	22.5	1.1	1.9	37.7	28.6	1.1	1.1	10.7	0.0	4.1	1.4	1.2	1.1	1.4	1.1	1.1	20.0	6.2	1.2	1.1	1.1	1.1	10.2	24.0	1.1	8.0	1.1	0.9	1.7	13.8	1.5	1.2	0.0	1.1	1.5	1.2	1.1	1.1	1.1	10.2	1.1	35.4	1.1	16.5	0.0	1.2	0.0	1.1	2.2	0.4	0.3	0.2	1.5	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	9.4	9.6	0.2	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.8	0.2	0.0	0.2	0.0	0.0	18.5	22.5	37.7	28.6	20.0	6.2	10.2	24.0	13.8	16.5
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;NTERA-2: 7.2;RPMI-8226: 7.9;SK-BR-3: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	7.9	0.0	0.0	0.5	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Group enriched"	"Detected in some"	10	"Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: "	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favourable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	40.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	2.0	0.0	0.5	11.7	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.4	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favourable (1.39e-4)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.8	9.5	6.3	7.8	12.0	6.9	7.1	3.2	8.7	7.5	8.9	7.8	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.6	6.6	5.1	8.3	4.5	7.3	6.9	5.4	6.8	3.7	7.3	1.2	9.4	6.0	8.5	6.3	5.7	6.4	9.9	6.2	3.8	2.4	5.3	6.4	7.8	18.1	5.0	11.6	6.8	10.9	5.8	4.3	10.7	6.7	7.2	6.6	9.1	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favourable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	12.8	0.0	0.0	3.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	12.2	0.7	0.0	2.2	0.0	0.9	0.0	0.0	0.0	0.0	10.5	0.8	0.2	21.1	0.0	0.0	0.0	0.0	10.1	5.7	2.2	8.0	2.8	0.0	0.0	7.4	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977766	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 35.7;tongue: 19.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.1;hTCEpi: 4.9;hTERT-HME1: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 5.6"					"Not detected"	"Not detected"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"			7100	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	2.1	0.4	0.2	0.4	0.1	0.0	2.2	0.1	0.1	1.1	0.6	0.0	0.0	0.1	0.4	8.6	1.9	0.3	0.3	2.0	0.2	0.2	0.4	0.2	0.7	8.5	0.2	0.7	0.2	0.2	1.0	0.9	0.9	0.1	0.2	0.6	0.0	0.6	0.0	0.9	35.7	0.3	0.5	0.2	0.3	0.2	0.9	0.0	0.8	0.2	19.4	7.8	0.8	1.1	0.6	0.5	1.9	0.4	0.6	5.6	1.0	0.4	0.1	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.0	7.1	0.0	0.1	0.5	0.9	0.6	0.4	0.0	0.3	1.6	0.0	4.9	0.8	9.6	0.0	0.2	2.3	0.0	1.0	0.0	0.2	0.1	0.1	0.6	0.0	0.8	0.2	0.6	0.0	0.2	0.2	0.3	0.0	0.5	0.1	0.1	0.3	0.7	0.1	0.1	0.3	0.1	0.6	0.4	0.1	0.0	1.7	0.4	0.4	4.8	0.2	5.6	0.3	3.1	1.8	0.2	0.6	1.6	2.5	1.9	0.6	0.3	0.5	1.1	1.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.7	0.1	0.0
H1F0	"H10, H1FV"	ENSG00000189060	"H1 histone family member 0"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 158.1"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"				"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favourable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	21.7	13.6	27.5	14.7	24.9	158.1	32.3	35.7	41.7	48.2	37.9	20.4	11.3	35.8	42.7	18.5	66.0	31.7	38.5	30.3	23.5	17.6	33.2	90.6	22.8	15.0	16.0	23.8	48.5	43.5	20.2	25.6	33.6	23.5	43.7	34.0	28.3	43.2	12.4	53.5	53.2	59.2	28.0	18.6	16.3	34.6	15.2	18.8	56.3	36.1	33.4	32.0	24.9	45.2	0.1	6.3	12.5	9.0	0.1	2.4	4.7	20.7	9.0	28.0	12.4	7.4	6.8	39.8	16.9	35.3	49.5	70.7	36.6	33.1	0.0	4.2	14.0	40.6	0.0	11.6	35.3	0.1	2.0	35.1	3.3	24.4	25.9	0.0	0.1	6.3	20.8	24.8	28.0	13.1	0.0	0.0	3.8	34.3	5.8	3.4	10.8	44.5	9.7	16.7	7.1	7.8	5.6	6.4	36.1	46.6	31.8	61.5	24.8	21.9	8.7	3.7	113.0	16.6	3.4	0.0	2.3	0.1	4.6	12.6	10.7	12.5	7.6	11.3	0.1	9.0	0.1	0.0	0.8	0.2	6.3	0.1	2.4	0.3	4.2	0.1	7.7	5.7	0.2	4.7	27.5	24.9	35.7	41.7	23.5	17.6	16.0	23.8	23.5	18.8
HES6	bHLHb41	ENSG00000144485	"Hes family bHLH transcription factor 6"	Q96HZ4	2	238238267-238240662	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell line enhanced"	"Detected in many"		"NB-4: 50.4;SCLC-21H: 33.4;SK-MEL-30: 48.2;U-937: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061763			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nucleoli, Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA061763: "	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.79e-4)"	"prognostic favourable (9.18e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.35e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.49e-2)"	2.1	5.2	15.4	3.4	10.6	10.5	3.0	7.3	47.4	3.7	12.2	17.1	0.8	18.1	6.3	1.5	1.6	14.3	5.7	1.7	17.5	9.1	1.9	2.5	2.2	3.3	11.4	12.3	1.3	13.9	5.3	23.6	1.7	14.3	2.0	9.6	1.5	3.8	1.7	8.2	1.7	12.9	3.3	18.8	4.6	5.2	9.4	11.7	0.4	5.5	1.7	2.8	1.3	1.0	0.3	1.4	8.0	0.3	0.1	1.0	0.2	1.2	1.4	6.4	7.2	0.4	0.2	4.1	0.4	0.4	0.6	0.9	1.1	0.8	0.0	1.0	0.1	0.8	6.5	0.4	0.2	2.8	7.8	1.4	1.0	13.1	1.0	10.5	8.8	0.6	4.0	0.9	1.3	0.4	13.3	0.1	0.4	3.2	1.6	50.4	10.2	1.1	7.1	16.2	3.0	0.8	0.6	33.4	14.6	1.9	2.9	48.2	2.5	22.4	0.6	0.6	1.3	3.5	3.7	3.0	0.5	2.2	2.2	25.7	1.1	0.1	0.3	8.0	1.0	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.3	1.4	0.7	0.2	15.4	10.6	7.3	39.3	17.5	9.1	11.4	12.3	14.3	11.7
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090839-96839562	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.7"	"Cell line enriched"	"Detected in some"	6	"RT4: 19.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"		9800	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: "	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	0.9	4.5	1.5	0.0	1.9	0.0	0.0	0.4	18.7	1.9	0.0			0.2	2.1	2.2	0.2	0.1	0.0	0.2	3.2	2.7	0.7	0.0	0.0	0.0	0.9		0.0	2.1	0.0	0.7	0.0		0.1	0.0		0.0	0.1	0.6	0.1	0.0	1.6	0.4	0.0	0.7	0.1			2.4		0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.2	1.0	0.8	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 35.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol				Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (5.27e-4)"	"prognostic favourable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	2.5	0.1	0.3	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Group enriched"	"Detected in some"	9	"PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.8	5.5	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	0.0	3.0	0.0	84.9	57.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: "	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	93.4	41.7	0.6	3.9	17.7	2.8	4.2	0.8	0.4	0.0	2.9	7.8	0.7	0.0	0.3	2.3	7.7	0.0	0.1	0.4	4.3	29.3	0.0	0.0	115.0	0.3	3.1	0.7	1.2	0.4	0.1	4.0	0.7	0.0	0.1	0.1	0.1	0.0	0.2	0.0	2.6	1.9	0.0	0.0	1.7	1.1	0.0	1.6	0.1	0.0	8.0	0.5	13.4	0.3	0.0	0.0	0.0	3.1	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: "	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	16.7	13.5	18.7	12.5	20.7	25.3	20.0	17.3	18.1	14.5	17.0	13.4	11.6	17.0	16.1	17.9	13.6	14.4	12.3	19.3	18.3	15.3	18.2	21.4	15.4	12.1	16.5	11.5	15.0	16.0	17.3	20.7	11.2	17.4	18.1	15.4	10.4	14.8	13.7	28.2	14.1	21.0	16.6	19.3	15.9	14.9	12.6	13.8	22.1	31.1	15.9	15.4	13.8	12.6	20.6	27.6	33.3	17.0	27.1	21.9	14.0	12.5	6.7	15.4	15.9	15.2	18.2	11.2	14.9	15.5	18.8	19.6	9.4	14.3	18.1	8.3	16.7	7.3	16.8	21.5	23.4	18.9	10.2	13.6	10.9	13.2	24.5	23.9	12.4	17.1	28.0	18.6	28.1	17.2	20.2	14.3	20.2	13.2	28.0	14.9	6.6	10.3	14.4	16.7	13.8	17.5	8.5	16.6	13.3	10.5	17.4	16.3	14.1	14.1	11.2	12.4	12.7	13.3	15.9	22.1	20.4	27.0	13.7	16.4	24.4	33.3	15.9	24.1	17.9	16.8	20.0	20.6	20.6	20.2	18.0	19.3	21.6	20.2	12.1	27.1	17.0	27.6	21.9	14.0	18.7	20.7	17.3	18.1	18.3	15.3	16.5	11.5	17.4	13.8
INTS14	"C15orf44, DKFZP564O1664, VWA9"	ENSG00000138614	"Integrator complex subunit 14"	Q96SY0	15	65578753-65611289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040255, HPA040651"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria"				"Nucleoplasm, Nuclear bodies, Mitochondria"	"Nuclear membrane"	"HPA040255: AB_10805710, HPA040651: AB_10796559"	"unprognostic (2.92e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.30e-1)"	16.6	20.2	12.1	14.1	14.9	13.1	20.2	12.0	19.1	20.1	20.0	20.8	17.3	12.3	25.5	25.3	19.6	22.3	18.4	12.4	11.3	12.9	22.7	23.2	14.4	17.5	14.1	10.4	20.2	22.0	16.1	23.5	23.5	13.9	18.9	21.6	19.9	27.5	21.7	11.8	17.5	19.9	17.0	11.9	23.5	17.5	19.7	9.9	32.4	26.1	16.1	24.0	17.7	16.2	13.4	13.6	12.9	8.6	14.8	20.3	10.4	12.1	22.0	22.2	17.7	12.4	15.6	14.3	13.4	17.4	22.4	20.8	19.6	28.8	19.9	18.9	16.7	24.7	47.3	22.6	19.8	17.4	28.7	17.3	16.4	21.2	24.7	17.7	22.3	15.1	22.5	17.0	26.2	24.2	23.7	11.6	15.7	19.3	20.1	17.1	16.2	12.2	17.3	18.7	22.8	17.4	22.7	16.0	12.7	16.2	16.5	22.4	15.4	20.7	11.8	15.5	16.3	13.8	21.2	11.5	21.4	26.9	15.6	32.4	18.0	12.9	7.5	3.9	14.3	8.6	16.2	13.4	14.8	16.3	13.6	10.5	15.7	14.3	0.8	14.8	6.2	12.0	20.3	10.4	12.1	14.9	12.0	19.1	11.3	12.9	14.1	10.4	13.9	9.9
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823514	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"		250000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.5	15.5	3.1	5.3	3.7	5.8	9.6	1.6	5.7	17.9	11.1	2.9	5.8	4.6	17.3	7.5	12.3	6.9	17.8	25.0	4.5	2.0	4.6	13.6	8.3	16.8	3.4	2.7	7.5	2.1	2.4	3.0	7.3	2.6	10.0	5.3	8.4	4.7	8.7	3.7	3.5	8.7	16.2	4.0	30.5	10.9	10.2	2.7	1.0	35.4	7.2	3.6	7.4	8.4	0.0	0.7	2.1	0.2	0.0	0.0	0.4	0.2	0.0	4.6	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	10.6	0.0	3.4	1.5	0.0	0.2	4.1	0.0	0.0	0.1	0.6	8.5	0.2	0.2	0.2	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.2	0.6	12.7	0.1	0.6	0.7	0.0	3.3	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.2	6.6	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.1	3.7	1.6	5.7	4.5	2.0	3.4	2.7	2.6	2.7
ITGB1BP1	"ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B"	ENSG00000119185	"Integrin subunit beta 1 binding protein 1"	O14713	2	9403475-9423547	"Predicted intracellular proteins"	"Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067348, HPA071538"			Supported	"Nucleoplasm,Nuclear bodies,Centriolar satellite,Cytosol"				Nucleoplasm	"Nuclear bodies, Centriolar satellite, Cytosol"	"HPA067348: , HPA071538: "	"unprognostic (2.21e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (4.39e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavourable (4.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (3.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.08e-3)"	61.1	15.0	19.0	11.6	29.2	16.1	73.0	17.6	24.0	24.5	16.3	9.9	10.2	7.7	18.0	16.6	13.3	15.0	14.4	23.9	17.1	15.6	23.6	7.7	13.4	12.1	19.7	18.7	14.3	7.6	14.8	9.7	14.1	19.4	11.1	14.8	11.4	7.7	15.1	16.0	16.6	8.6	22.1	19.2	8.6	11.2	5.6	17.0	10.2	11.2	12.1	14.8	12.8	33.6	20.7	29.5	35.2	27.3	24.1	31.3	24.9	16.0	11.5	13.6	15.5	48.5	41.2	7.4	29.4	20.2	26.6	20.7	15.3	10.0	17.7	13.3	40.3	15.2	20.7	19.2	29.4	47.7	10.5	16.1	13.6	19.0	16.9	12.4	17.6	23.2	15.9	24.3	17.4	23.2	9.0	14.7	32.9	14.3	21.9	8.1	11.0	19.3	12.6	18.6	16.4	26.9	13.2	14.8	14.3	16.4	12.6	19.8	9.3	9.4	14.7	23.9	17.6	31.8	32.6	14.7	31.6	25.9	32.7	17.1	16.5	35.2	23.0	27.9	30.4	27.3	28.9	20.7	26.5	29.4	29.5	17.5	20.6	26.5	5.0	24.1	20.0	26.6	31.3	24.9	19.0	29.2	17.6	24.0	17.1	15.6	19.7	18.7	19.4	17.0
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 75.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"				"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: "	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	13.2	7.9	16.2	14.0	22.6	9.1	22.7	16.7	26.0	11.7	12.2	10.7	10.5	9.6	13.5	12.5	28.8	10.9	10.2	9.0	11.2	9.0	9.1	10.9	20.2	10.7	13.8	10.3	10.9	14.3	8.7	10.4	75.0	15.0	11.9	13.6	8.9	10.5	9.0	7.4	19.7	9.4	16.1	17.8	12.0	11.0	11.0	12.8	7.5	8.3	8.6	12.3	10.2	19.1	9.1	10.2	46.0	6.8	4.3	8.9	4.5	17.9	15.7	25.1	16.8	20.3	20.4	18.7	24.4	14.9	19.6	19.6	8.9	10.0	8.8	16.1	15.8	23.7	12.2	14.0	23.2	18.0	6.6	15.5	16.6	10.5	14.2	16.2	16.8	12.1	20.7	13.3	26.2	35.0	16.5	18.4	26.6	8.7	10.1	13.3	18.4	12.5	15.7	15.3	8.2	18.1	24.2	14.2	12.7	15.0	11.0	7.2	13.6	19.4	20.0	26.7	13.7	23.6	19.3	11.5	15.4	18.0	23.9	17.7	19.8	16.5	6.8	10.3	7.0	6.3	8.9	8.5	7.7	7.2	7.4	9.1	8.6	7.6	46.0	4.3	4.0	10.2	6.3	4.5	16.2	22.6	16.7	26.0	11.2	9.0	13.8	10.3	15.0	12.8
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell line enhanced"	"Detected in some"		"RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: , HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	1.1	1.8	0.0	0.3	0.3	2.1	0.6	2.9	0.2	0.3	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	1.4	0.0	0.5	0.5	1.1	1.5	0.0	0.7	7.4	0.9	0.0	0.4	7.0	4.3	0.4	0.4	0.0	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	0.9	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0
KCTD1	C18orf5	ENSG00000134504	"Potassium channel tetramerization domain containing 1"	Q719H9	18	26454910-26657401	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 35.6;HaCaT: 37.0;hTCEpi: 33.5;RPTEC TERT1: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA057808, HPA062486"			Approved	"Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite"				Nucleoplasm	"Nucleoli, Cytokinetic bridge, Centriolar satellite"	"HPA057808: , HPA062486: "	"unprognostic (1.15e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.35e-4)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (3.65e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.77e-2)"	"prognostic favourable (4.60e-8)"	"unprognostic (3.87e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.02e-2)"	3.9	11.8	15.9	2.1	37.3	0.7	22.2	13.7	29.0	12.6	5.0	6.9	6.2	3.2	10.0	15.8	32.8	33.8	5.8	12.9	16.7	6.7	20.1	2.6	4.0	2.0	6.6	18.4	11.1	5.2	7.4	6.1	17.2	6.8	15.3	7.3	8.4	12.5	16.4	2.8	39.3	2.2	8.7	6.0	2.9	7.0	4.1	10.7	5.7	13.6	20.1	11.7	8.5	18.3	0.3	0.7	0.7	0.3	0.0	1.8	0.2	5.4	19.0	35.6	3.8	20.9	3.4	4.5	4.6	7.0	7.4	7.3	1.8	6.3	1.1	17.7	9.8	37.0	6.8	10.0	6.9	1.0	3.2	1.1	4.2	3.0	3.9	0.6	1.8	5.7	33.5	2.1	13.9	6.9	0.4	0.5	5.2	7.8	5.4	1.7	3.6	8.7	2.9	2.1	0.8	32.6	8.2	3.7	14.1	6.7	9.2	3.1	8.3	1.5	3.7	8.2	2.6	1.6	5.1	1.7	1.4	0.1	3.1	3.7	12.2	0.0	0.1	0.7	0.8	0.1	1.6	0.0	1.8	0.6	0.7	0.3	0.7	0.5	0.0	0.0	0.3	0.3	0.0	0.2	15.9	37.3	13.7	29.0	16.7	6.7	6.6	18.4	6.8	10.7
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: , HPA061066: "	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.2	4.4	9.1	8.9	0.2	0.2	2.0	1.9	2.2	4.3	5.3	1.9	3.7	0.0	2.0	0.4	4.2	11.8	3.8	3.8	0.6	7.5	0.1	6.9	1.7	1.6	1.1	0.2	1.0	7.0	3.9	4.9	0.1	2.9	0.1	0.4	2.3	3.6	2.5	0.4	1.0	1.4	0.3	0.0	9.9	0.8	27.9	9.7	3.6	8.5	2.5	8.5	1.2	0.0	0.6	2.2	1.3	2.8	4.1	9.2	0.0	1.7	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947711	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 12.3;lymphoid tissue: 34.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"				"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.7	0.6	0.5	8.2	0.4	12.3	0.4	0.4	0.5	0.9	1.6	0.3	0.7	2.9	0.5	0.6	3.2	0.3	1.3	1.5	0.5	0.5	0.5	0.7	0.8	5.9	0.6	0.1	0.6	0.4	0.0	0.4	1.9	0.2	0.5	1.5	0.1	0.7	0.1	0.4	2.9	2.5	0.8	0.4	1.7	1.5	3.8	0.1	34.7	0.4	2.7	7.6	0.7	1.1	1.1	0.8	2.0	0.6	1.0	1.4	0.4	14.2	18.6	15.9	14.9	0.3	1.3	13.4	12.2	4.6	15.4	12.1	15.4	12.3	12.6	5.3	4.6	15.7	11.0	4.9	7.8	26.0	16.4	16.3	20.9	9.5	0.0	13.4	14.3	0.3	0.2	13.3	5.3	7.8	12.2	21.5	7.9	11.1	24.9	13.3	11.7	12.8	19.1	24.3	8.4	2.5	7.7	12.0	11.7	8.2	7.4	4.5	13.9	9.6	5.1	23.0	22.8	13.6	25.6	6.9	6.8	15.5	7.4	10.2	14.8	1.8	0.6	0.4	0.5	0.3	0.4	0.8	0.7	0.5	0.3	1.1	0.4	0.5	2.0	1.0	0.3	0.8	1.4	0.4	0.5	0.4	0.4	0.4	0.5	0.5	0.6	0.1	0.2	0.1
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701610-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031263, HPA050214"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"				"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA031263: AB_10602610, HPA050214: "	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	3.9	2.3	1.3	5.9	6.6	11.1	3.2	12.8	3.0	4.1	3.8	0.7	1.1	4.3	3.4	2.2	7.0	3.3	1.5	2.2	2.1	1.3	2.4	3.2	2.8	9.5	1.6	2.6	4.3	2.0	2.1	3.2	4.0	3.6	2.3	5.1	1.5	3.4	2.0	2.1	4.9	5.5	3.0	3.0	8.0	3.0	10.2	2.6	26.2	2.8	3.9	9.1	2.8	3.8	13.3	4.8	8.3	3.9	2.4	8.6	1.9	35.5	7.3	10.7	9.4	2.1	3.6	8.9	14.6	13.4	15.3	16.2	9.6	16.5	13.8	4.6	7.4	18.1	11.8	8.2	20.7	16.6	8.1	14.0	12.7	8.2	0.6	23.8	11.6	1.5	1.2	14.8	15.2	9.8	13.3	15.9	13.6	6.1	13.9	4.6	10.9	7.0	9.7	21.0	6.0	4.8	4.8	3.4	6.1	10.5	4.8	5.5	12.4	6.9	7.7	9.9	9.9	12.8	23.4	4.4	12.0	18.6	9.3	21.2	7.3	8.3	2.3	3.7	5.5	3.9	6.7	11.5	7.4	5.9	1.2	13.3	8.6	8.0	0.1	2.4	3.8	4.8	8.6	1.9	1.3	6.6	12.8	3.0	2.1	1.3	1.6	2.6	3.6	2.6
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	7.5	12.5	15.9	7.9	20.7	2.9	6.6	51.7	49.4	7.4	7.8	7.5	6.5	8.5	11.3	6.0	8.8	9.0	8.0	15.3	20.0	17.4	6.7	2.4	6.6	7.5	13.8	26.0	11.3	11.2	15.4	15.4	6.4	29.0	13.6	4.4	8.2	8.4	15.5	23.8	9.3	7.7	10.1	8.6	6.6	9.8	17.4	10.0	13.5	6.3	4.5	5.6	8.8	8.5	4.7	4.1	0.8	0.4	2.3	6.2	1.5	20.2	24.8	12.1	7.2	7.3	5.9	9.4	14.3	10.3	14.7	11.4	13.5	6.1	9.1	13.8	10.6	17.1	12.4	13.9	4.9	14.6	15.6	1.8	19.6	9.1	14.2	4.0	9.7	5.9	18.4	17.2	14.1	6.8	9.8	12.4	11.7	28.5	22.9	6.1	11.9	20.6	8.8	6.3	12.4	11.5	11.4	33.0	16.0	10.4	9.4	17.1	15.5	2.8	11.2	24.2	21.7	29.2	18.8	12.9	10.8	4.9	17.1	2.8	9.7	0.0	0.4	0.8	4.6	0.1	6.2	3.6	2.2	3.1	0.6	4.7	2.2	2.7	0.7	2.3	0.3	4.1	0.6	1.5	15.9	20.7	51.7	49.4	20.0	17.4	13.8	26.0	29.0	10.0
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"				Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: "	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	28.7	9.1	2.5	7.0	3.5	11.8	33.1	8.2	4.4	12.9	13.0	5.1	10.8	3.5	12.8	11.7	8.3	11.2	11.6	19.4	2.9	2.3	12.7	27.9	14.6	15.9	5.5	2.4	13.7	38.3	7.3	2.4	9.9	3.4	13.9	4.7	9.2	11.3	10.9	14.0	19.1	7.7	30.4	3.5	16.1	10.2	16.7	2.7	1.5	9.1	8.5	5.6	11.1	42.7	2.9	6.6	1.7	12.7	5.4	2.7	3.8	3.7	1.8	4.4	0.3	3.0	5.4	10.6	4.3	4.4	2.5	2.6	4.2	8.7	0.0	7.8	5.2	0.8	3.7	3.3	1.6	25.5	2.9	1.9	5.3	0.8	3.0	7.7	12.4	8.4	12.5	4.7	1.3	2.1	5.1	17.2	2.5	4.4	0.0	1.4	7.0	3.7	4.1	0.1	7.2	6.0	4.6	5.6	3.5	6.6	13.7	12.7	3.2	10.6	6.1	10.9	9.2	8.2	1.4	15.7	18.6	10.1	2.8	2.1	5.8	0.0	6.9	1.7	2.6	11.0	0.8	2.8	1.7	1.8	6.6	2.9	0.5	1.0	0.2	5.4	12.7	0.3	2.7	3.8	2.5	3.5	8.2	4.4	2.9	2.3	5.5	2.4	3.4	2.7
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: "	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favourable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	69.8	10.0	8.4	26.3	10.6	80.6	101.1	7.4	10.1	28.6	31.7	10.3	9.7	11.0	24.9	28.8	38.6	28.0	38.6	18.6	7.8	5.1	32.2	32.5	46.0	35.8	13.8	4.2	20.2	23.8	7.5	4.7	26.1	11.2	20.1	21.0	13.2	26.9	16.5	57.8	60.2	44.8	42.8	17.0	20.3	26.7	14.3	10.0	12.5	41.0	28.8	21.5	44.7	30.7	15.6	29.8	77.8	18.7	13.0	30.8	23.2	13.0	3.5	6.8	2.2	39.6	39.8	4.3	22.5	11.5	24.1	16.4	9.1	17.6	3.7	5.2	24.3	7.9	4.2	20.7	20.1	18.3	2.5	0.5	4.1	8.6	17.0	2.4	12.9	13.1	39.6	17.1	32.7	24.5	4.1	29.2	30.5	0.9	4.5	3.8	2.5	6.4	3.0	7.0	13.1	23.6	13.0	3.0	2.9	5.5	16.0	33.7	7.9	2.0	31.9	32.5	4.5	19.2	10.3	5.6	18.2	6.9	8.7	3.3	10.0	50.9	17.0	43.7	27.1	14.2	23.9	15.6	30.8	26.8	13.1	12.5	9.6	14.8	77.8	13.0	18.7	29.8	22.2	23.2	8.4	10.6	7.4	10.1	7.8	5.1	13.8	4.2	11.2	10.0
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.6	2.8	2.1	20.7	11.7	2.9	12.1	6.2	6.7	16.5	12.2	3.7	0.0	1.4	14.0	0.2	1.6	3.1	2.7	5.0	1.1	3.6	1.1	2.4	29.8	0.0	0.3	41.7	0.0	30.6	0.2	3.2	0.0	0.0	8.6	2.1	0.0	0.0	5.4	0.7	0.0	9.2	0.0	6.1	1.1	0.1	6.9	2.0	10.1	6.3	13.2	0.0	1.5	6.7	13.5	27.0	8.1	1.6	1.9	0.8	1.3	0.9	8.7	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023302-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.1	4.9	7.1	7.0	9.3	12.0	4.5	20.3	10.8	4.6	7.0	5.7	9.5	11.1	4.4	5.0	8.0	10.5	5.8	3.1	7.7	3.9	5.9	12.9	5.6	6.5	8.3	4.7	3.7	15.5	4.5	4.8	4.9	6.5	6.6	3.6	4.9	13.6	5.0	4.3	10.2	9.4	5.2	3.3	7.6	10.4	3.1	9.9	7.1	9.8	6.8	6.5	5.0	5.1	2.3	3.3	5.0	3.2	2.8	4.6	3.1	9.7	11.1	3.4	6.9	1.4	1.9	13.2	6.8	2.8	4.1	3.5	9.9	6.7	7.3	6.2	1.3	11.4	3.2	4.1	0.9	4.4	20.9	4.6	20.2	13.3	1.1	5.4	11.6	1.8	1.7	2.4	0.6	6.0	3.2	3.2	1.0	16.5	12.1	18.1	3.5	14.9	10.0	6.6	4.0	2.6	9.0	10.5	10.2	3.1	16.3	5.7	13.3	6.3	3.5	7.2	9.1	11.4	11.5	6.3	1.6	1.1	3.9	4.7	7.5	5.0	3.2	3.6	3.9	2.4	4.0	1.5	4.5	4.6	2.2	2.3	2.4	3.1	0.2	2.8	1.0	3.3	3.8	3.1	7.1	9.3	20.3	10.8	7.7	3.9	8.3	4.7	6.5	9.9
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.3;HEL: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	10.3	0.2	0.0	0.0	0.0	0.5	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 15.8;hTCEpi: 33.3;SCLC-21H: 9.1;SiHa: 8.2;U-138 MG: 9.0;U-2197: 13.1;U-87 MG: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	15.8	33.3	0.1	1.1	0.2	0.0	0.0	0.0	0.5	0.1	3.8	1.4	0.0	0.0	0.0	0.0	0.3	0.2	9.1	0.7	8.2	0.8	2.0	0.8	0.1	0.2	9.0	0.1	13.1	0.0	0.0	0.0	0.0	8.7	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;HDLM-2: 22.6;U-251 MG: 22.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_10600302, HPA027270: AB_10600884"	"unprognostic (1.05e-2)"	"prognostic favourable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	3.7	3.4	3.0	14.7	4.0	3.4	2.7	4.9	3.6	5.0	7.3	4.5	3.5	6.0	5.5	3.3	6.8	4.2	6.2	4.5	3.0		4.4	5.1	4.9	12.0	3.0	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4.0	4.5	4.5	7.1	2.2	6.9	18.0	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.4	22.0	2.2	3.9	1.5	3.7	5.6	2.6	1.8	8.3	5.1	3.4	11.6	4.2	13.3	2.7	6.6	1.0	3.5	4.3	22.6	1.7	0.9	6.0	1.5	4.0	0.7	4.4	5.8	2.2	4.1	2.2	1.6	1.8	18.0	4.2	3.4	3.9	1.5	1.2	3.1	5.2	6.7	9.5	6.0	1.9	2.3	1.9	4.0	2.7	2.8	1.7	0.4	3.5	3.8	5.9	3.2	22.1	17.2	6.4	2.2	2.1	2.4	5.1	1.5	3.4	1.6	3.5	3.6	2.0	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3										
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: "	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.13e-4)"	"prognostic favourable (7.26e-4)"	"prognostic unfavourable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.4	6.9	6.2	6.9	8.7	15.3	1.6	9.3	5.4	7.0	5.3	2.0	10.0	0.1	8.3	14.1	11.8	2.1	6.5	3.5	6.2	5.1	0.5	16.0	3.1	2.7	0.5	0.6	12.2	15.9	7.3	2.6	4.7	2.3	4.1	11.1	18.4	0.3	8.4	1.9	5.7	2.7	4.1	1.7	10.5	7.8	2.3	3.4	9.8	8.6	7.3	4.6	6.4	9.8	17.6	7.4	19.7	4.8	3.3	4.1	0.1	15.6	6.1	5.1	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857362-113863471	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 74.3;TIME: 58.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.1;neutrophil: 15.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"			17000000	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: , HPA067595: , HPA069443: "	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	13.0	5.0	11.2	17.0	12.9	26.9	16.0	18.5	43.3	12.1	23.2	17.9	0.9	11.6	9.7	4.0	17.0	8.4	10.9	9.7	10.5		5.3	8.7	12.9	13.3	8.8	15.9	12.6	11.2	1.2	6.5	39.5	13.8	14.1	21.6	11.4	8.2	5.6	5.0	9.5	12.9	9.1	42.3	20.9	18.8	5.2	8.5	30.0	4.9	7.9	13.6	23.5	7.8	3.9	0.9	15.0	10.1	0.0	0.0	0.4	6.8	4.0	74.3	4.0	25.1	16.4	0.4	22.0	31.0	15.6	26.1	7.2	9.7	0.0	4.6	40.6	21.2	12.2	6.4	20.3	0.0	7.3	0.0	4.3	9.3	16.7	1.7	0.1	16.9	12.6	15.0	14.3	43.9	0.8	19.6	22.1	0.0	0.2	0.0	9.6	5.3	0.0	7.4	0.7	4.9	13.1	10.3	30.1	14.1	7.2	15.1	0.3	2.0	58.3	14.5	0.0	23.7	37.5	53.0	3.8	2.0	11.1	9.8	27.7	0.0	3.4	0.0	0.0	10.1	0.0	3.9	0.0	0.0	0.9	1.6	0.0	0.0	15.0	0.0	5.5	0.0	0.0	0.4										
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 26.6;NTERA-2: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.5	4.5	4.7	4.4	7.7	7.4	4.7	3.1	2.3	3.6	4.4	10.3	1.7	13.7	3.6	3.2	4.0	12.1	4.2	6.4	5.3	8.1	14.9	5.8	6.7	3.0	19.2	3.7	4.5	3.6	9.5	8.8	6.3	26.6	3.3	3.5	5.5	3.0	7.3	25.9	4.0	6.0	8.9	3.4	3.1	6.5	8.6	3.8	4.4	2.7	2.8	1.9	8.5	8.0	2.4	4.4	3.2	7.2	3.8	4.2	6.7	3.3	11.0	4.1	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	"O94851, Q6ZW33"	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 138.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 39.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 138.4;cerebral cortex: 39.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: , HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.1	3.3	15.4	7.3	15.1	6.8	2.9	138.4	39.8	6.6	14.7	2.7	2.9	7.2	14.7	7.7	11.5	5.4	11.1	24.8	22.0	6.9	2.9	3.9	12.8	2.3	5.6	17.9	3.9	4.4	0.7	2.4	5.0	5.5	3.3	15.1	2.8	2.9	8.4	14.6	9.3	10.8	22.7	7.6	2.6	5.9	24.6	0.6	0.0	4.5	1.9	2.2	7.8	3.2	0.2	5.5	12.2	6.7	3.7	3.5	2.1	11.6	6.2	0.2	1.4	1.6	2.9	7.4	18.6	21.1	7.3	11.4	13.0	8.4	0.3	4.0	13.0	8.2	2.2	30.0	18.2	13.5	1.5	11.0	1.2	0.9	14.1	2.0	1.4	5.2	5.3	32.2	31.5	16.6	19.3	0.5	11.7	0.7	0.1	1.0	0.4	5.8	0.1	7.4	7.8	1.5	14.7	6.1	0.5	6.1	17.1	1.2	1.7	0.6	29.7	39.8	15.0	6.5	16.2	0.4	0.9	0.4	24.2	2.9	0.8	0.1	6.7	0.5	2.8	1.7	3.5	0.2	1.7	1.7	5.5	0.2	0.2	0.9	12.2	3.7	0.5	1.0	2.1	2.1	15.4	15.1	138.4	39.8	22.0	6.9	5.6	17.9	5.5	0.6
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024559	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2"	"Group enriched"	"Detected in many"	6	"B-cells: 5.2;granulocytes: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"				"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: "	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	10.1	9.0	15.4	20.7	19.2	10.2	9.6	62.2	25.0	12.8	22.4	30.0	8.8	8.3	30.3	14.0	13.8	28.6	9.5	23.7	15.4	13.8	8.7	16.8	6.1	15.2	21.6	15.6	20.2	10.2	30.4	11.0	11.9	19.4	11.8	16.5	14.2	8.0	14.8	28.0	14.7	13.2	26.1	20.9	12.2	11.1	15.7	22.6	3.0	10.4	7.8	20.8	14.7	15.1	5.2	0.3	10.0	0.1	1.3	1.1	0.2	13.7	15.1	8.0	13.0	6.0	7.8	9.7	12.1	13.2	17.2	13.6	14.4	1.9	15.4	6.2	16.5	15.9	11.8	14.0	16.7	14.9	11.2	16.0	16.1	6.0	4.0	7.1	8.6	6.3	11.2	18.1	19.2	10.0	17.5	9.9	6.3	12.3	6.7	4.4	5.5	9.9	9.4	12.0	0.7	13.8	9.7	21.2	8.3	17.1	10.9	25.8	4.3	3.0	17.6	17.7	11.4	12.1	25.2	6.5	11.5	20.6	15.4	3.2	50.7	10.0	0.0	0.1	0.5	0.1	0.8	3.3	0.6	0.5	0.1	5.2	0.3	0.2	0.2	1.3	0.0	0.3	1.1	0.2	15.4	19.2	62.2	25.0	15.4	13.8	21.6	15.6	19.4	22.6
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219409-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA071751	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitochondria"				"Nucleoplasm, Mitochondria"	"Nucleoli, Plasma membrane"	"HPA071751: "	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	26.9	32.3	19.0	20.9	26.8	13.6	26.1	24.6	31.8	25.1	21.0	20.1	21.8	16.5	28.6	23.7	33.6	26.3	18.0	43.6	18.9	17.5	25.1	30.9	14.9	27.4	18.1	21.7	33.9	25.1	24.5	23.7	17.5	23.5	26.2	26.4	25.5	31.0	26.5	43.7	23.9	17.5	25.0	17.5	22.2	20.9	12.1	12.6	34.2	32.1	26.7	32.4	25.9	21.0	19.6	23.3	6.1	14.1	21.5	21.5	16.1	16.3	22.0	19.6	32.3	25.8	33.3	25.2	15.8	22.7	30.1	24.3	27.3	23.3	42.5	22.2	18.4	18.3	38.0	56.1	32.7	16.0	23.5	21.8	26.5	30.1	25.7	19.1	17.0	31.1	23.7	31.5	35.4	32.0	21.8	12.9	24.9	19.7	28.5	23.2	22.6	13.8	30.4	32.6	43.5	27.8	17.6	30.3	16.2	26.5	21.9	19.6	33.6	23.3	18.1	12.3	18.2	17.3	28.3	13.1	19.6	30.0	21.2	31.5	19.4	6.1	12.1	4.1	14.0	14.1	20.6	19.6	17.4	17.0	23.3	16.5	20.3	21.5	1.8	21.5	11.3	8.9	17.8	16.1	19.0	26.8	24.6	31.8	18.9	17.5	18.1	21.7	23.5	12.6
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	6	"K-562: 9.1;U-266/70: 26.0;U-266/84: 8.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	26.0	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 41.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favourable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.4	3.0	0.4	0.0	0.1	3.4	5.3	4.0	3.3	0.0	0.5	1.4	0.0	5.8	0.1	1.8	0.7	8.5	0.7	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	0.7	0.0	9.7	0.5	1.0	0.5	0.0	2.3	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.2	2.5	0.0	1.7	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.6	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"		20	58981208-58995133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262"			Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: , HPA066262: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	9.1	11.1	10.2	9.4	13.0	8.8	12.7	18.1	13.7	10.2	10.8	15.2	9.2	8.4	11.2	8.2	14.6	12.5	8.6	9.2	10.9	8.2	16.4	15.9	7.9	11.2	16.7	13.4	15.4	10.3	19.1	18.1	12.1	12.5	10.2	8.9	9.4	14.7	9.1	12.0	11.9	8.8	8.1	11.8	9.2	8.9	26.1	12.4	17.4	14.4	10.0	13.6	9.8	11.3	22.7	29.6	9.4	27.7	19.4	24.6	20.5	12.5	14.5	17.5	18.6	6.0	10.7	11.2	10.2	10.0	31.0	18.0	48.0	18.1	16.6	16.1	10.2	22.0	23.4	25.8	25.1	5.1	16.6	21.9	18.2	37.5	7.2	15.6	15.0	11.3	8.3	11.3	7.9	17.8	29.0	12.7	14.1	49.9	33.7	23.6	10.1	32.2	18.9	14.5	30.7	13.0	19.5	19.3	28.7	31.9	38.5	21.2	41.5	18.3	7.1	23.9	22.7	9.3	16.9	10.1	18.6	16.9	14.2	13.9	20.6	7.2	20.4	9.4	20.3	22.8	23.9	22.7	19.3	24.6	29.6	20.0	18.9	19.9	2.2	19.4	27.7	15.0	17.6	20.5	10.2	13.0	18.1	13.7	10.9	8.2	16.7	13.4	12.5	12.4
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	9	"HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"				Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: "	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	9.3	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: "	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	5.6	4.7	7.3	4.7	11.2	7.2	4.9	6.3	12.0	5.4	3.5	4.9	8.9	4.4	5.2	11.9	3.7	17.4	5.7	3.7	6.6	3.9	4.5	2.5	6.7	4.6	2.8	6.4	7.0	4.9	7.1	17.8	3.7	5.4	4.5	2.9	8.3	4.1	5.7	3.7	9.6	4.5	5.3	3.5	4.6	4.3	11.4	3.7	5.8	14.9	3.7	2.6	4.3	4.5	0.5	0.4	2.6	1.0	0.5	0.8	0.4	7.5	4.2	5.6	4.4	5.1	7.4	4.4	4.0	4.1	5.6	4.4	4.0	6.7	4.0	10.0	4.5	7.1	2.8	6.8	2.8	4.9	6.4	3.3	7.7	3.6	3.5	6.6	5.2	5.9	3.4	6.6	4.2	3.9	6.1	4.3	2.5	5.6	8.0	6.6	0.9	4.5	6.9	3.6	6.5	2.5	1.0	17.9	5.5	6.2	4.6	6.6	6.1	7.2	3.5	8.1	3.4	13.3	4.8	5.2	6.8	4.0	3.4	8.3	2.1	2.6	1.0	0.0	0.5	0.2	0.8	0.3	0.5	0.0	0.4	0.5	0.4	0.0	1.4	0.5	0.8	0.3	0.2	0.4	7.3	11.2	6.3	12.0	6.6	3.9	2.8	6.4	5.4	3.7
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.2;HaCaT: 21.3;RPMI-8226: 4.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: "	"prognostic favourable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772491-128775790	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 11.4;retina: 23.9"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.26e-8)"	"prognostic unfavourable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (9.33e-4)"	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1.0	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1.0	0.7	1.3	0.7	0.7	0.0	0.7	0.7	0.7	1.4	0.0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0.0	1.4	0.3	1.6	2.2	5.1	1.7	0.0	0.0	1.5	9.6	0.0	0.0	0.0	5.0	2.0	2.5	1.4	0.0	1.4	0.0	0.0	0.0	0.3	3.6	1.5	3.0	2.5	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.6	1.0	0.7	2.0	3.5	4.6	2.9	1.0	5.3	2.9	0.0	0.6	0.7	6.8	2.3	5.2	4.3	0.5	1.9	4.0	9.8	1.0	7.6	8.6	2.0	2.1	1.5	36.9	4.5	9.1	0.0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1.0	1.2	0.5	0.3	0.9	0.0	0.0	1.0	0.7	0.4	0.3	0.7	0.9	1.0	0.9	0.7	0.8	0.7	1.3	0.7	0.7
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	1.4	1.3	2.7	0.9	11.7	1.0	1.1	6.8	7.9	1.4	1.2	2.7	0.5	1.0	2.8	3.9	1.3	1.1	0.8	3.9	3.5	2.8	1.2	0.5	1.2	1.0	2.5	2.5	2.9	2.5	2.8	6.1	2.3	5.4	1.5	0.9	2.4	1.1	1.0	1.7	1.5	0.6	1.8	2.4	1.1	0.8	2.7	1.1	0.0	1.3	0.6	0.7	1.2	0.9	1.2	0.9	2.7	0.5	0.8	1.0	0.2	0.1	0.4	0.5	1.9	1.2	2.0	0.3	1.7	1.1	0.5	1.0	0.4	0.2	0.5	2.8	1.0	0.2	0.2	0.3	1.1	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.2	1.7	0.5	0.0	0.7	0.1	0.2	0.8	6.9	0.1	0.2	0.8	0.3	0.3	3.0	2.6	0.3	0.3	0.3	1.7	2.1	0.2	0.9	1.7	11.3	0.4	0.8	3.2	0.7	1.6	0.4	0.3	1.0	0.2	3.8	0.2	5.1	2.7	0.5	0.5	0.7	0.4	0.4	0.7	0.7	0.5	0.2	1.2	1.0	0.8	1.1	0.8	0.5	0.9	0.6	0.2	2.7	11.7	6.8	6.1	3.5	2.8	2.5	2.5	5.4	1.1
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 33.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	5.2	4.2	7.9	1.6	11.4	1.2	2.7	2.4	33.7	3.6	2.9	9.8	1.2	2.4	3.0	2.4	4.3	3.6	3.7	2.3	9.1	4.4	2.0	6.5	3.5	1.7	5.1	7.2	3.6	1.9	1.4	2.4	7.4	5.3	3.6	2.6	4.9	4.1	4.6	2.0	4.7	2.9	3.1	6.7	2.5	4.7	2.0	6.5	0.0	4.9	1.5	3.3	2.5	3.5	0.9	1.1	1.5	0.7	0.8	1.0	0.2	0.0	0.0	12.0	6.1	5.3	2.3	5.7	2.0	0.1	2.9	4.7	0.2	0.7	0.6	7.9	2.9	0.3	2.8	1.9	2.3	0.7	0.0	0.0	0.3	0.0	2.1	1.2	0.2	13.5	0.3	2.0	0.8	1.1	0.0	0.1	7.3	0.0	0.1	0.3	1.1	0.1	0.1	1.0	0.0	2.0	0.0	1.6	0.6	0.3	0.0	0.3	16.0	1.5	2.6	5.5	0.3	9.4	0.1	0.2	0.9	0.1	2.8	0.0	0.3	1.5	0.3	0.3	1.0	0.4	1.0	0.6	0.4	0.6	0.1	0.9	0.4	0.9	0.9	0.8	0.7	1.1	0.3	0.2	7.9	11.4	2.4	8.5	9.1	4.4	5.1	7.2	5.3	6.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.4	14.9	16.1	0.5	3.2	6.2	2.5	4.0	0.0	0.1	0.3	5.4	3.2	2.1	0.1	0.3	4.0	0.1	1.4	0.0	0.0	0.0	2.5	0.2	0.0	11.5	0.1	4.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	9.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.3	1.8	4.5	0.5	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell line enhanced"	"Detected in some"		"BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"											"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.6	12.6	0.0	0.0	0.0	0.0	0.4	0.0	18.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	14.0	0.0	3.7	0.0	4.4	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	6.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA038625: "	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.9	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.4	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.1	0.2	0.1	0.3	2.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AF22: 11.0;BJ: 3.6;EFO-21: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	4.0	4.5	11.7	1.4	10.5	0.7	2.5	6.9	13.7	4.7	1.3	7.9	0.0	0.7	4.5	3.5	1.5	2.9	3.5	12.2	8.5	5.8	2.5	2.5	2.6	1.0	6.6	7.7	8.6	3.6	1.8	6.3	5.7	8.7	3.0	1.3	4.6	2.9	3.2	1.5	1.9	1.1	3.6	6.0	1.5	1.2	5.2	3.8	0.0	3.3	1.3	1.0	1.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.1	0.2	1.5	0.0	3.6	0.3	0.0	0.1	0.0	0.0	0.1	8.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.5	6.9	13.7	8.5	5.8	6.6	7.7	8.7	3.8
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355025-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	5.4	4.7	6.5	1.8	8.3	0.5	3.0	8.5	11.2	4.8	2.0	10.4	1.5	1.2	5.0	3.0	1.9	3.4	3.1	4.8	6.3	5.9	2.0	2.7	3.6	0.9	5.6	8.1	5.8	6.7	8.5	3.4	2.8	6.1	4.1	1.4	3.5	4.3	4.2	1.5	1.8	1.2	5.0	5.9	1.3	1.4	2.7	4.0	0.0	2.6	2.7	0.9	2.3	2.5	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	1.0	0.6	4.5	10.2	0.0	5.6	4.5	0.3	1.1	0.0	0.1	0.9	1.9	4.7	0.1	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.4	5.9	0.2	0.1	0.0	5.6	0.2	0.3	2.4	0.8	0.3	0.2	0.2	0.2	0.3	1.6	0.1	0.3	0.0	0.8	1.7	0.2	0.3	1.1	2.1	0.0	3.6	2.4	0.7	3.1	0.4	0.2	0.3	0.2	8.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.3	8.5	9.3	6.3	5.9	5.6	8.1	6.1	4.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Group enriched"	"Detected in some"	7	"ASC diff: 18.4;ASC TERT1: 7.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.4	0.3	0.1	18.4	7.3	0.0	0.8	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.6	0.1	0.6	0.7	0.3	0.5	0.7	0.1	0.3	0.9	0.6	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	1.6	0.0	1.0	0.6	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.7	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373914-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	4.1	3.8	6.1	2.3	8.4	0.8	2.9	19.6	10.8	7.9	3.4	8.3	2.9	1.0	6.9	4.7	2.6	4.3	3.6	3.7	5.0	4.3	2.8	1.7	3.3	1.4	2.9	4.7	9.7	2.5	2.5	4.5	6.9	3.3	4.0	1.6	5.8	4.1	5.3	2.1	4.7	1.5	6.1	2.8	2.8	1.7	2.2	2.9	0.2	3.8	1.2	1.5	4.6	3.6	1.3	0.7	2.8	0.6	0.5	0.8	0.2	0.1	0.3	3.1	0.5	1.5	5.3	0.1	2.3	0.8	1.2	1.2	0.0	0.2	2.1	3.0	3.6	0.5	0.1	0.5	0.8	0.0	0.3	0.0	0.3	0.3	0.8	0.1	0.1	5.7	0.4	0.3	0.1	1.8	0.3	1.3	0.4	0.5	0.7	1.8	0.3	0.1	1.5	0.4	0.0	0.4	0.1	11.0	0.9	0.1	0.3	0.7	6.4	0.1	5.4	0.9	0.4	0.8	0.8	0.4	1.8	0.4	0.9	0.7	13.7	1.8	0.6	0.3	0.8	0.3	0.3	0.8	0.6	0.2	0.1	1.3	0.3	0.5	2.8	0.5	0.3	0.7	0.5	0.2	6.1	8.4	19.6	10.8	5.0	4.3	2.9	4.7	3.3	2.9
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	1.4	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.6	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.4	0.2	0.9	0.2	0.2	0.5	0.7	2.7	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.7	0.3	0.9	0.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.3	1.0	2.5	0.2	0.5	0.4	1.2	0.0	1.0	1.1	0.4	0.6	2.0	5.9	3.1	0.1	0.2	0.3	1.1	0.1	0.5	0.0	0.2	0.0	1.8	0.1	0.4	6.6	0.3	0.6	0.5	1.6	0.1	0.3	0.5	0.6	0.3	0.7	0.3	0.1	0.3	0.7	0.0	0.3	0.3	0.7	1.8	0.6	0.1	0.8	1.5	0.7	7.2	0.5	0.5	0.1	3.9	0.3	0.1	0.1	8.3	0.2	1.4	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"				"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: , HPA076182: "	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.1	1.8	0.0	14.9	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.2	0.2	3.3	1.9	0.4	0.3	0.2	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: , HPA077526: "	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	4.9	3.6	11.3	2.2	9.7	0.9	3.7	8.7	12.2	7.2	2.4	11.6	0.3	1.2	9.2	3.2	3.2	5.6	6.2	4.6	9.3	7.0	2.7	2.7	5.4	1.4	7.0	8.6	9.0	2.6	7.5	3.0	3.9	7.3	4.4	2.8	3.1	2.4	4.4	1.9	2.9	2.1	5.0	7.0	2.2	2.0	1.8	7.8	0.1	2.6	1.3	1.4	2.8	3.3	0.9	0.9	0.5	0.0	0.0	0.7	0.0	0.1	0.3	2.1	0.2	14.4	10.5	0.1	2.2	3.0	0.6	3.4	0.0	0.3	3.8	1.0	1.7	0.5	0.5	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.6	0.2	0.2	2.7	0.5	0.2	0.1	1.7	0.2	1.2	8.5	0.4	2.9	0.6	0.1	0.9	7.8	2.7	0.2	0.2	0.3	1.6	1.7	0.2	0.4	0.4	3.1	0.2	6.0	3.0	0.7	4.6	3.9	0.2	2.2	0.7	3.3	1.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.9	0.0	0.0	11.3	9.7	8.7	10.6	9.3	7.0	7.0	8.6	7.3	7.8
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370264-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: "	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	4.1	1.7	3.3	1.6	6.5	0.5	3.1	3.5	5.6	3.0	3.0	7.2	0.7	0.7	4.9	3.7	3.3	3.3	2.9	4.6	3.3	2.3	2.9	2.0	2.5	3.7	1.9	3.8	5.2	4.2	4.6	5.4	2.3	2.6	2.6	2.2	3.1	6.6	2.6	1.9	3.3	1.4	4.3	2.9	2.4	2.3	1.5	2.8	0.3	3.4	3.2	3.5	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.4	0.3	13.2	10.7	0.2	1.4	2.4	0.9	1.1	0.0	0.0	2.2	0.4	4.3	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.3	0.1	0.6	0.1	0.0	2.6	0.6	0.2	0.1	1.2	0.3	1.0	0.3	0.4	0.7	1.0	0.1	0.1	1.8	0.7	0.0	0.2	0.1	3.0	0.6	0.0	0.0	0.3	0.8	0.0	6.7	0.6	0.1	0.7	0.7	0.3	2.0	0.2	0.6	0.6	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.5	3.5	5.6	3.3	2.3	1.9	3.8	2.6	2.8
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 28.5;TIME: 14.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	7	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	2.4	2.2	2.4	0.7	4.2	0.0	1.2	1.8	2.1	2.6	1.4			0.2	3.2	3.5	1.1	2.1	0.8	2.8	2.3	4.1	2.9	3.3	2.1	0.0	1.8		5.1	1.9	3.0	2.5	6.2		2.6	0.7		3.0	3.1	1.2	3.4	0.3	1.9	2.0	0.6	0.4	0.9			3.6		0.2	1.6	2.0	0.0	0.2	0.0	0.0	1.6	0.2	0.2	0.0	0.7	7.0	0.0	4.6	5.9	0.8	6.8	28.5	2.8	1.9	0.0	0.0	0.2	5.5	0.2	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.6	1.8	0.0	0.0	5.7	0.0	2.7	0.0	4.3	0.2	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	2.6	14.3	3.8	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2										
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.1	1.9	0.8	0.3	3.2	0.0	3.6	2.0	4.3	1.4	0.4	2.5	1.9	0.0	2.1	2.5	1.1	2.1	0.8	1.9	0.0		1.6	3.1	6.8	2.6	0.9	1.5	4.9	2.8	11.2	2.1	9.5	1.5	2.2	0.2	3.7	3.2	3.2	1.4	2.6	0.0	1.9	3.0	0.5	0.7	1.0	2.2	0.8	3.5	0.0	0.7	1.9	1.4	0.5	0.2	0.0	0.3	0.0	1.9	0.1	0.0	1.1	0.1	0.0	32.2	24.3	0.6	8.5	0.0	13.9	15.6	1.3	4.6	4.8	11.1	9.4	6.4	0.0	3.5	7.8	0.0	1.4	0.0	0.0	0.0	3.3	0.0	3.1	8.5	0.7	0.8	4.5	4.2	0.1	0.0	0.4	3.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1										
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	6.7	7.2	8.8	2.6	9.9	1.6	4.4	6.1	26.6	5.8	4.1	10.1	0.3	1.8	7.2	5.7	3.0	5.1	4.4	4.6	8.9	5.7	3.2	9.4	4.4	2.2	6.9	4.4	13.3	5.2	16.1	4.7	6.8	5.9	4.0	2.3	9.0	5.3	5.9	5.7	4.7	2.2	4.8	4.1	4.0	2.5	2.1	6.7	0.3	6.1	1.9	2.1	4.2	5.1	0.8	0.5	3.2	0.4	0.5	0.9	0.2	0.0	0.1	18.2	0.1	0.6	0.7	0.9	1.6	0.0	0.4	1.0	0.2	0.2	1.5	6.2	1.0	0.3	0.0	0.3	1.2	0.0	0.3	0.0	0.2	0.1	1.5	0.1	0.1	4.2	2.0	0.9	0.1	0.6	0.1	0.3	0.1	0.3	0.1	1.2	0.8	0.0	0.2	0.1	0.1	2.9	0.2	0.2	0.3	0.0	0.1	0.1	1.4	0.4	2.9	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.8	1.1	0.4	0.2	0.9	0.3	0.2	0.6	0.4	0.2	0.1	0.8	0.4	0.3	3.2	0.5	0.3	0.5	0.2	0.2	8.8	9.9	6.1	7.9	8.9	5.7	6.9	4.4	5.9	6.7
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 42.5;HSkMC: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	10.1	9.8	12.6	3.8	13.5	0.8	8.0	19.1	12.9	10.2	7.0	16.1	1.2	2.3	11.6	5.0	6.8	7.8	9.2	8.5	14.5	7.9	5.4	3.5	11.6	2.6	10.4	7.3	17.3	5.5	9.5	5.3	11.0	9.4	8.3	3.8	15.5	7.1	12.0	5.6	6.8	3.2	10.5	20.1	5.3	4.5	4.2	14.3	0.6	8.4	3.0	2.3	4.6	6.9	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	42.5	1.0	0.2	0.4	2.8	0.3	1.0	2.1	0.0	2.6	0.3	2.3	5.6	0.7	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	3.2	0.2	0.0	13.5	0.3	0.8	0.4	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	4.7	0.9	0.0	0.1	0.0	4.6	6.3	0.1	0.0	0.0	0.4	0.4	5.5	5.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.6	13.5	19.1	12.9	14.5	7.9	10.4	7.3	9.4	14.3
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell line enhanced"	"Detected in some"		"REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.2	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.9	0.9	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.5	0.0	9.7	0.6	0.0	0.0	0.1	8.2	15.9	0.1	0.0	0.2	0.1	0.3	0.1	0.9	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0"	"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	16.3	0.2	0.2	7.0	0.0	0.0	0.0	10.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2a"	O14813	11	72239077-72245664	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7"	"Cell line enriched"	"Detected in single"	228	"SH-SY5Y: 112.7"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in single"	96	"pons and medulla: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"pons and medulla: 0.8"	"Low region specificity"	"Detected in some"			"HPA053810, HPA065621, HPA078004"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA053810: , HPA065621: , HPA078004: "			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	24.6	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.5	0.0	0.4	0.1	0.0	1.4	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	12.1	0.9	0.7	1.7	0.7	3.7	0.0	0.0	3.2	0.3	2.1	0.1	1.6	5.2	0.0	0.0	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	112.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11148762	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							"HPA015986, HPA031974, HPA031975, HPA040616"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: "	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	0.9	0.3	3.1	0.9	2.3	0.0	1.9	0.1	3.6	0.9	3.3			0.0	0.3	1.6	5.8	0.8	5.9	0.0	5.2	2.1	0.9	4.5	7.4	0.5	5.8		0.6	1.7	0.0	0.6	0.0		3.4	1.3		0.0	3.3	0.0	0.8	0.9	1.9	10.3	2.7	1.4	0.9			1.3		0.2	4.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.0	0.0	0.5	2.7	10.5	14.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.7	0.0	0.3	0.0	23.4	5.5	3.3	0.0	0.0	0.0	0.1	2.7	0.7	3.2	0.0	0.2	1.6	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.1	0.0	3.2	8.1	0.0	0.1	0.0	0.5	0.0	2.7	0.0	0.0	3.8	0.2	0.5	14.9	0.1	9.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 41.2;HMC-1: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody				Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: "	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	22.6	9.8	4.2	3.5	3.9	5.2	28.7	5.3	5.1	5.4	5.8	10.5	8.6	9.1	14.5	5.2	9.7	5.5	8.4	9.7	11.6	6.2	41.2	6.7	6.3	4.0	10.0	65.3	4.4	6.5	3.8	7.7	8.1	15.7	6.8	6.7	10.3	5.8	7.0	6.0	9.2	4.2	4.4	6.5	8.3	12.5	3.7	2.7	14.7	6.4	18.9	16.0	23.9	8.5	3.5	4.4	7.5	7.4	11.5	7.5	8.3	8.5	9.7	4.8	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 57.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	7.3	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4										
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"				"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: , HPA057913: "	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.3	9.2	18.2	10.9	12.2	13.9	11.8	13.8	12.8	15.6	16.2	9.7	16.8	9.2	16.5	13.1	18.4	17.7	10.5	21.3	3.3	12.9	6.8	19.0	8.3	10.7	6.7	2.0	11.4	11.0	12.2	14.8	17.7	11.3	6.7	16.7	4.7	7.7	5.8	9.1	10.7	7.4	27.7	3.8	13.8	46.0	8.8	5.8	20.7	12.0	17.8	8.9	6.1	16.5	13.2	11.9	16.9	14.4	3.7	3.2	6.3	5.5	6.6	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160904-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;ASC TERT1: 17.2;HSkMC: 12.2;hTERT-HME1: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: "	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	1.9	3.6	2.4	3.5	2.9	2.1	2.5	11.0	2.7	7.6	3.8	4.1	9.0	3.4	3.4	9.8	2.0	7.5	2.1	6.8	1.9	1.8	3.7	1.2	4.6	6.7	4.8	2.1	11.6	2.2	2.1	17.8	8.0	4.6	5.1	1.6	7.9	7.5	9.2	1.4	3.4	5.5	2.5	6.3	6.2	3.0	5.2	4.5	11.7	3.5	1.5	5.2	4.8	7.0	3.5	0.2	1.1	0.5	0.7	4.6	1.0	1.5	0.0	9.5	0.1	13.0	17.2	3.0	4.2	5.5	2.0	0.9	0.6	4.9	0.2	4.1	2.3	0.3	2.6	5.6	2.0	0.1	5.8	6.0	0.5	1.4	2.7	1.9	1.8	12.2	3.1	1.1	12.6	3.7	2.5	0.1	4.2	0.0	0.5	3.6	2.7	1.4	4.7	0.7	3.7	2.6	0.5	0.1	0.0	0.1	0.0	0.3	0.1	1.8	5.6	2.9	3.8	4.7	1.0	1.5	1.1	2.2	3.3	0.7	0.8	1.1	0.1	1.1	0.3	0.1	0.2	3.5	1.0	0.6	0.1	2.0	4.6	4.3	1.0	0.7	0.5	0.2	0.2	1.0	2.4	2.9	11.0	2.7	1.9	1.8	4.8	2.1	4.6	4.5
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: , HPA065323: , HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favourable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	12.8	2.9	17.2	7.8	36.9	11.4	19.8	7.3	29.4	15.2	15.9	67.3	9.3	10.2	31.6	9.9	26.4	19.8	17.5	12.5	24.2	12.8	19.5	16.5	8.4	4.0	40.7	21.6	16.8	22.7	17.9	3.7	22.3	19.5	12.3	12.1	13.6	19.6	31.6	5.9	19.6	10.0	20.7	24.5	16.0	11.5	5.1	40.9	1.2	14.5	6.4	5.3	16.6	17.1	0.0	0.7	16.7	1.9	6.4	12.2	2.9	28.5	13.3	11.1	16.8	1.2	0.0	19.3	3.2	3.8	5.1	4.1	14.0	12.6	0.0	5.8	3.1	27.6	7.5	25.4	1.7	0.0	6.5	12.7	16.4	3.3	1.5	0.4	6.1	1.5	14.8	1.0	9.2	3.3	0.0	0.1	1.7	13.5	0.0	11.6	3.7	14.2	0.1	5.5	1.9	14.0	20.9	3.8	6.8	6.6	9.9	9.5	10.8	2.8	6.4	2.2	23.0	0.1	4.4	0.0	0.0	0.0	0.2	1.3	3.9	4.5	1.9	11.7	12.2	1.1	8.6	0.0	3.7	5.2	0.7	0.0	0.4	2.7	16.7	6.4	0.7	0.0	1.1	2.9	17.2	36.9	7.3	29.4	24.2	12.8	40.7	21.6	19.5	40.9
PLEKHH2	"KIAA2028, PLEKHH1L"	ENSG00000152527	"Pleckstrin homology, MyTH4 and FERM domain containing H2"	Q8IVE3	2	43637273-43767987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.1;RPTEC TERT1: 8.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077225			Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA077225: "	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.82e-2)"	10.1	2.7	3.7	9.2	6.5	0.3	7.5	5.4	5.6	27.2	8.5	2.9	3.6	4.1	30.0	9.5	5.2	9.8	8.1	3.7	4.2	2.7	8.7	1.8	21.7	3.0	3.4	3.3	19.4	2.5	9.6	1.8	4.2	8.3	7.9	5.0	7.4	3.8	7.8	5.4	6.9	5.7	13.1	9.7	4.7	4.1	4.2	4.0	0.0	4.7	4.7	4.3	11.1	8.6	0.8	0.6	1.4	0.4	0.7	1.0	0.0	0.6	5.1	2.1	0.1	4.2	10.1	0.4	0.7	2.6	1.0	2.7	0.0	1.8	1.3	0.3	0.8	3.4	0.6	0.8	2.0	0.1	1.5	0.1	0.7	0.2	0.6	0.0	0.7	2.9	0.8	2.6	0.1	2.3	4.8	0.2	0.9	1.4	0.9	0.2	1.1	5.1	0.0	6.1	0.1	8.3	0.3	1.6	0.8	0.5	0.0	5.1	0.7	0.2	0.2	6.0	1.7	0.3	1.8	1.2	0.3	0.0	2.4	0.0	0.6	0.8	0.4	0.4	0.4	0.2	0.4	0.3	0.7	0.5	0.2	0.8	1.0	0.6	1.4	0.7	0.3	0.6	0.5	0.0	3.7	6.5	5.4	5.6	4.2	2.7	3.4	3.3	8.3	4.0
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.9"	"Cell line enhanced"	"Detected in all"		"U-698: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane, Centrosome"	"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favourable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	31.6	7.2	7.1	7.6	9.8	7.7	13.5	14.8	7.1	7.9	8.2	13.6	5.7	7.7	6.3	5.6	7.9	5.0	7.8	4.6	7.4	5.0	10.3	94.9	5.4	6.2	12.6	3.4	8.7	18.5	5.4	19.4	6.7	9.8	4.6	8.5	6.6	8.8	4.0	6.2	6.7	9.4	5.9	8.7	4.2	11.9	28.6	13.9	10.1	6.1	7.2	9.4	6.0	5.1	11.5	14.7	9.9	11.9	14.1	14.3	12.0	12.8	8.6	12.4	8.4	12.5	6.8	12.5	12.7	8.9	9.5	8.7	29.2	13.5	16.3	9.6	8.2	12.2	18.4	10.4	12.2	11.2	5.7	15.9	5.1	12.7	6.2	18.5	12.7	7.7	6.3	10.7	7.9	11.7	19.2	21.7	10.4	4.2	20.0	7.5	15.3	9.4	15.4	8.3	19.9	14.1	14.2	4.1	11.0	11.4	10.5	2.1	12.1	6.9	12.6	11.1	13.4	5.5	8.1	2.3	5.7	59.6	3.9	21.7	14.0	5.4	10.0	9.9	13.7	11.9	13.4	10.4	13.9	12.7	14.7	11.5	12.3	13.1	2.5	14.1	10.7	6.3	14.3	12.0	7.1	9.8	14.8	7.1	7.4	5.0	12.6	3.4	9.8	13.9
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"				"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.4	39.7	33.2	22.6	3.5	6.0	17.8	46.8	27.7	51.9	39.7	26.5	31.7	12.4	18.6	29.8	44.3	37.8	20.0	49.1	22.9	41.9	25.6	51.9	24.3	0.8	12.6	22.2	1.5	2.6	29.4	30.2	29.0	21.3	26.6	48.2	28.2	12.9	19.3	13.0	17.0	13.6	41.5	16.6	23.1	24.7	30.3	24.0	44.5	24.8	16.1	29.7	25.0	17.3	34.3	30.3	28.3	67.4	8.6	22.8	15.3	15.0	31.4	52.3	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8
PRPF40B	HYPC	ENSG00000110844	"Pre-mRNA processing factor 40 homolog B"	Q6NWY9	12	49568218-49644666	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038426, HPA038599"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Aggresome,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Aggresome, Cytosol"	"HPA038426: AB_10674684, HPA038599: AB_10674689"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.50e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.80e-2)"	6.2	12.3	16.6	5.8	12.6	1.5	9.7	15.6	20.3	12.8	8.8	11.7	13.2	5.5	14.7	13.8	8.5	15.2	8.3	16.3	12.6	10.6	12.9	5.5	6.6	4.1	13.3	14.5	22.0	10.3	30.3	17.5	11.8	12.0	11.0	4.9	10.4	14.2	17.9	22.3	13.1	4.7	10.4	9.6	7.3	8.9	25.1	12.9	2.3	19.4	5.5	5.2	9.9	9.1	1.8	1.5	0.0	0.4	3.1	3.5	0.8	5.1	7.5	7.6	7.4	6.3	4.1	7.0	4.2	5.9	4.5	2.3	8.7	11.5	4.1	9.0	5.5	3.0	4.6	14.6	2.3	3.0	1.8	4.3	2.8	3.1	8.0	1.4	5.8	5.8	12.4	4.5	16.4	3.5	2.1	2.2	5.4	4.8	1.0	2.9	3.2	2.8	3.6	1.2	3.3	9.5	4.7	8.1	9.8	3.4	9.5	5.1	18.0	4.0	1.5	2.8	11.3	3.6	1.8	5.3	3.0	1.6	8.4	1.1	2.5	0.0	0.4	0.0	2.4	0.3	3.5	1.1	2.3	1.1	0.6	1.8	2.7	2.9	0.0	3.1	0.2	1.5	1.0	0.8	16.6	12.6	15.6	20.3	12.6	10.6	13.3	14.5	12.0	12.9
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 25.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Mitochondria"				Nucleoli	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: "	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.5	1.0	2.2	1.3	5.8	3.5	0.8	2.6	2.9	1.0	0.5	0.7	0.6	0.7	0.8	0.8	1.0	0.9	1.1	0.3	1.8	1.6	0.7	0.9	0.6	0.9	0.9	0.8	0.9	0.5	1.0	0.8	1.2	1.7	0.9	0.5	0.6	1.0	0.8	0.6	1.3	0.8	0.7	1.6	0.7	0.6	25.8	1.0	1.3	0.8	0.3	0.9	0.8	0.5	3.1	2.3	2.8	2.2	2.6	2.9	1.3	3.9	6.0	3.3	4.4	0.2	0.3	3.5	2.3	1.8	5.3	5.1	2.5	3.7	0.7	6.9	1.9	1.3	1.5	1.7	1.2	2.6	1.5	4.1	3.5	1.4	1.2	1.1	2.5	1.8	2.3	3.5	0.7	0.9	2.2	2.0	2.4	9.2	3.9	2.0	3.5	0.0	1.5	0.6	0.4	1.8	3.4	7.5	3.0	3.2	2.3	0.9	3.0	1.4	1.2	3.5	5.2	0.9	3.1	0.4	1.4	1.2	3.8	2.9	3.6	2.8	2.2	0.6	2.4	1.8	0.8	3.1	1.7	2.3	2.3	2.2	2.3	1.3	2.4	2.6	0.7	1.5	2.9	1.3	2.2	5.8	2.6	2.9	1.8	1.6	0.9	0.8	1.7	1.0
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell line enhanced"	"Detected in some"		"A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	11.3	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	21.8	0.0	3.9	0.0	17.7	0.0	0.0	0.0	2.8	0.2	0.0	4.5	0.0	0.0	0.0	3.6	0.0	24.0	0.0	0.1	0.0	0.1	1.3	0.1	6.3	0.0	0.1	0.1	8.2	0.0	0.6	0.2	0.0	13.8	0.2	1.2	1.3	4.3	0.0	13.3	0.8	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.2	0.2	0.6	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"			160000	Nucleoli	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	34.8	33.3	24.3	23.0	35.4	34.6	28.8	42.4	46.3	33.4	25.2	33.1	13.5	36.9	22.1	39.2	20.9	31.2	37.6	55.7	28.0	25.7	53.7	31.0	18.1	35.4	43.0	34.3	28.0	37.9	35.9	51.1	27.6	40.7	13.0	32.2	25.2	30.2	20.9	29.4	21.8	31.1	35.9	21.2	30.8	39.2	16.9	20.8	40.8	31.3	26.0	36.0	29.9	33.6	39.4	35.3	23.4	37.1	25.2	41.5	36.9	32.7	30.2	36.8	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase, non-receptor type 21"	Q16825	14	88465778-88554733	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centriolar satellite"	"CAB011468: AB_442979, HPA073999: "	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favourable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.5	4.7	5.3	8.6	7.3	0.0	13.2	4.4	5.8	10.7	8.7	10.7	7.4	4.9	10.6	10.7	8.9	8.3	12.7	17.4	7.4	4.2	8.1	6.0	15.3	1.6	6.6	4.2	15.8	7.8	10.6	3.9	15.6	6.4	11.9	6.5	12.6	6.5	10.5	8.8	24.2	10.5	15.7	7.3	3.7	7.4	15.2	6.5	0.8	16.0	8.4	3.1	12.0	26.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	3.5	2.9	7.6	2.9	8.1	7.0	7.8	9.6	7.4	5.7	7.9	5.1	6.5	0.0	2.3	12.2	3.4	1.1	3.4	8.4	0.2	1.7	0.0	3.1	2.1	9.0	0.0	0.1	4.7	6.7	4.8	5.7	4.6	1.1	0.1	14.6	2.9	0.0	0.1	2.2	5.6	0.0	22.7	0.0	4.9	2.6	0.5	8.8	5.5	13.8	3.2	6.8	1.4	9.0	10.6	8.4	4.3	6.5	0.3	1.1	0.0	3.9	0.1	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.3	4.4	5.8	7.4	4.2	6.6	4.2	6.4	6.5
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: , HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.4	13.9	20.4	11.3	12.4	16.2	33.5	12.8	15.5	12.2	10.3	20.3	20.8	21.9	19.6	12.4	13.7	15.7	27.5	9.8	16.9	11.7	17.8	11.9	25.0	15.2	20.6	16.3	14.5	17.8	13.7	20.6	12.9	15.2	24.4	14.2	26.2	13.2	36.8	35.6	7.3	11.9	8.1	25.1	24.9	24.8	13.8	15.9	16.4	22.1	11.5	26.9	43.7	10.0	7.4	10.4	11.4	9.3	12.9	19.5	33.8	12.6	14.3	11.4	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"				"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: "	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.4	18.0	11.1	12.2	6.1	5.3	25.4	8.5	3.9	11.4	14.5	7.6	10.0	9.1	12.6	5.8	5.9	14.9	12.0	21.3	22.2	30.7	12.8	20.2	28.9	6.0	16.5	11.5	3.1	10.8	12.7	10.3	12.7	19.9	12.5	9.7	77.6	23.3	23.0	3.0	16.7	15.1	17.6	17.2	6.9	9.7	13.8	12.8	6.8	3.3	12.8	10.1	17.5	4.0	9.6	25.6	8.7	10.3	11.8	43.8	26.7	9.8	16.3	11.0	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823645	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.2;BEWO: 20.1;Daudi: 20.5;HL-60: 24.1;NB-4: 31.2;U-937: 38.4"	"Cancer enhanced"	"Detected in all"		"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: "	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	8.3	5.1	26.5	21.5	26.9	38.6	3.6	10.2	45.8	14.9	4.1	59.5	0.1	2.7	13.0	11.6	5.2	9.8	7.8	2.4	33.2	22.4	2.0	3.0	10.1	26.2	54.7	8.7	3.5	1.7	0.7	2.6	4.5	39.7	3.9	5.0	19.8	2.0	4.8	1.2	2.2	5.7	18.6	106.1	14.9	3.3	9.9	27.3	4.7	2.5	0.6	34.2	10.7	2.7	7.9	14.1	42.1	17.9	2.4	4.7	10.6	0.0	4.8	11.9	19.2	0.1	0.0	20.1	1.1	3.3	0.2	0.0	1.1	0.0	20.5	1.9	1.0	0.0	1.7	0.0	0.3	7.3	0.7	13.4	0.0	0.2	0.0	24.1	13.7	0.0	0.0	0.4	0.0	7.8	0.0	8.1	0.0	0.0	3.5	31.2	2.6	0.3	5.5	1.3	7.8	0.0	9.5	0.1	0.9	0.0	0.3	0.6	0.0	15.4	0.2	0.5	2.6	0.2	1.5	0.1	1.9	12.6	0.1	38.4	0.1	21.1	17.9	29.5	2.4	15.4	4.7	7.9	3.9	3.3	14.1	5.3	2.6	2.1	42.1	2.4	16.8	9.4	3.4	10.6	26.5	26.9	10.2	19.3	33.2	22.4	54.7	8.7	39.7	27.3
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713338	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6"	"Cell line enriched"	"Detected in some"	15	"RH-30: 24.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		1.2	2.4	19.9	1.5	33.0	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0.0	1.3	1.3	5.0	2.0	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0.0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0.0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	1.4	0.0	0.0	24.5	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	2.4	0.6	2.0	1.1	0.3	0.7	1.0	0.9	0.8	0.3	1.7	1.4	1.0	3.1	1.2	0.7	0.7	1.0	0.0	19.9	33.0	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237624-122264839	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Midbody,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Midbody, Cytosol"	"HPA057281: , HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favourable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	12.8	14.8	16.5	9.1	16.5	15.1	24.6	18.1	20.3	14.4	13.4	10.5	13.7	10.4	13.6	16.2	11.8	11.6	11.7	27.2	16.7	18.6	17.3	12.2	10.7	10.9	17.8	13.2	15.1	13.7	16.0	18.2	16.2	16.3	17.2	12.6	8.2	12.6	13.9	29.4	10.1	10.8	13.2	16.0	12.4	12.3	7.6	15.0	11.9	15.3	13.5	11.1	13.0	14.4	8.7	9.5	16.0	13.0	7.7	10.0	8.2	5.8	6.1	8.4	9.3	12.5	15.4	7.4	13.3	11.0	9.2	8.5	7.0	5.8	10.2	5.8	8.6	13.8	13.1	13.9	11.6	10.5	6.0	7.6	10.2	5.9	14.0	15.2	10.6	13.1	15.8	9.6	19.7	13.1	10.4	8.1	13.7	6.4	7.9	9.4	6.5	10.2	7.0	17.5	13.9	12.8	6.6	17.7	9.3	10.0	14.2	15.1	8.2	8.6	7.2	8.6	4.9	13.7	13.0	11.8	21.7	8.6	14.2	9.4	10.3	6.8	9.2	16.0	10.0	10.5	9.6	8.7	8.9	9.7	9.5	6.0	9.3	9.7	9.7	7.7	13.0	6.9	9.1	8.2	16.5	16.5	18.1	20.3	16.7	18.6	17.8	13.2	16.3	15.0
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644397-110839469	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.9;skeletal muscle: 20.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HEL: 4.8;K-562: 4.5;RH-30: 15.5;SH-SY5Y: 14.3;T-47d: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 4.6"	"Low region specificity"	"Detected in many"			"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"				"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytokinetic bridge"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.7	0.1	0.4	0.6	1.9	0.1	2.2	0.5	1.5	0.9	2.6	1.3	0.0	0.2	2.5	7.5	3.6	1.9	2.3	45.9	0.6	0.2	1.1	0.1	0.5	0.1	0.3	1.3	2.4	13.7	0.9	1.2	1.4	1.4	1.0	0.5	4.3	6.3	0.7	20.9	0.7	1.0	2.1	0.6	0.1	0.6	0.9	1.4	0.0	0.7	3.4	0.5	1.8	3.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	5.7	4.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.0	0.4	1.3	0.0	15.5	0.0	0.0	0.0	0.1	14.3	0.1	0.0	0.6	8.7	0.0	0.0	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.9	0.5	1.5	0.6	0.2	0.3	1.3	1.4	1.4
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"				"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	41.4	44.1	37.5	41.5	41.4	120.8	38.5	57.5	41.8	43.4	35.0	30.7	46.3	29.5	51.9	34.3	42.8	35.3	40.7	40.2	35.8	29.9	39.2	32.4	40.4	41.8	41.1	31.4	52.3	35.6	40.9	71.5	45.2	37.4	39.2	27.0	28.9	37.1	46.0	44.1	32.1	30.6	40.2	43.0	38.4	33.5	22.9	46.4	52.4	40.7	28.2	40.5	39.9	46.1	27.6	32.5	88.9	25.1	24.2	22.5	16.8	28.7	26.7	27.8	24.6	21.9	24.9	30.3	38.6	19.3	25.2	23.8	38.6	26.7	39.7	30.1	14.9	27.2	41.2	24.4	29.1	26.6	29.5	52.8	27.0	44.6	24.8	48.6	33.0	10.1	42.4	21.1	24.0	23.5	54.4	35.4	21.6	24.9	56.5	35.0	33.5	32.0	34.5	44.1	29.9	22.9	20.8	27.1	23.5	30.2	38.5	33.7	25.9	34.3	27.0	32.8	28.1	30.4	34.6	22.8	46.3	58.3	22.5	39.1	24.0	41.2	25.1	38.2	22.5	22.1	22.1	25.3	19.8	20.7	22.4	27.6	18.9	18.0	88.9	24.2	19.4	32.5	22.1	16.8	37.5	41.4	57.5	41.8	35.8	29.9	41.1	31.4	37.4	46.4
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357837-177372601	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.9;brain: 76.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 76.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5"	"Group enriched"	"Detected in all"	5	"amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"				Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: , HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	1.9	1.5	7.7	12.5	76.1	17.5	1.3	0.4	8.8	1.7	2.6	1.9	0.6	5.1	1.3	1.4	3.2	6.6	3.4	0.7	17.1	1.9	2.1	6.9	4.3	15.5	2.5	3.6	0.8	1.5	0.1	0.9	1.0	0.8	1.2	0.5	0.7	5.2	1.8	1.6	3.5	5.7	1.2	0.7	12.8	3.7	0.7	4.4	24.2	4.3	1.7	12.9	4.9	1.6	9.2	12.2	43.9	12.3	6.5	20.7	12.4	1.8	0.4	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.2	1.1	3.7	4.7	2.6	0.0	3.8	0.0	1.2	0.0	39.8	0.1	7.4	0.1	1.5	0.2	5.7	35.6	0.6	0.3	0.2	0.2	0.2	1.2	9.6	0.0	0.1	7.6	15.7	0.6	1.0	3.5	0.0	20.5	0.4	0.1	0.1	0.7	0.0	0.1	3.0	1.3	9.0	0.3	0.0	0.7	0.0	3.4	5.1	2.4	2.0	0.6	10.8	0.8	18.6	12.3	43.9	20.5	11.4	20.7	9.2	19.1	18.7	12.2	8.0	16.0	14.3	43.0	6.5	11.6	5.4	18.2	12.4	7.7	76.1	0.4	8.8	17.1	1.9	2.5	3.6	0.8	4.4
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871716-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"				"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	24.2	19.0	20.9	16.8	20.3	27.2	22.3	26.0	24.0	18.9	19.0	16.2	16.3	11.5	25.2	18.6	23.8	19.2	16.0	26.6	19.8	16.8	20.6	18.4	17.1	23.2	18.5	20.4	23.9	17.7	37.7	23.6	23.6	19.3	18.8	19.3	18.7	19.2	16.5	35.9	23.5	16.4	20.6	19.2	21.3	19.2	32.0	21.6	31.2	18.1	24.0	26.3	21.7	18.9	19.4	22.2	16.2	19.5	14.2	20.3	16.2	28.0	18.7	19.6	23.6	12.8	13.8	6.9	20.1	18.1	33.7	35.4	31.6	22.6	16.6	15.4	12.8	19.7	26.1	17.8	34.7	26.6	18.0	11.1	12.0	24.9	12.1	22.5	14.1	11.3	11.6	25.3	28.8	19.1	22.1	15.2	22.2	17.3	26.1	30.7	12.1	21.3	14.6	16.7	17.4	12.7	13.3	10.6	10.7	11.7	8.5	23.6	23.0	14.3	10.8	16.8	16.8	9.5	41.4	10.3	26.3	35.6	21.1	12.2	12.9	4.3	19.5	16.2	17.1	18.7	18.6	19.4	19.6	18.7	22.2	16.7	17.0	18.5	2.2	14.2	15.3	20.7	20.3	16.2	20.9	20.3	26.0	24.0	19.8	16.8	18.5	20.4	19.3	21.6
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridylate synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	9.5	9.7	12.0	16.5	14.8	20.9	10.4	15.3	23.8	7.4	11.2	9.4	6.2	17.6	10.5	14.0	13.9	8.6	11.2	8.1	12.7	10.4	10.7	13.4	8.2	18.2	9.5	11.3	10.0	15.3	9.9	8.9	8.2	11.2	11.3	5.1	10.9	19.8	10.5	11.1	16.8	12.8	8.3	7.0	17.4	15.1	6.2	9.2	15.5	8.5	15.1	15.6	10.8	10.7	17.3	23.1	17.7	19.9	18.0	20.4	15.8	10.5	12.5	3.1	13.9	2.7	3.2	14.3	8.8	5.1	11.6	8.5	29.1	10.0	14.8	9.7	4.2	18.2	7.1	8.9	2.1	13.4	28.8	7.3	19.2	10.5	4.4	13.4	12.3	4.7	8.6	10.0	2.6	8.0	17.0	6.7	3.9	33.6	16.7	14.1	15.7	21.6	29.8	8.3	30.4	4.2	6.5	16.1	11.6	10.2	16.7	9.7	8.6	16.8	9.0	11.6	15.1	12.1	12.7	10.7	10.7	17.0	5.6	10.5	9.5	17.5	19.9	17.7	18.3	18.0	18.1	14.9	15.5	20.4	23.1	17.3	16.2	16.3	12.7	18.0	17.4	21.2	18.7	15.8	12.0	14.8	15.3	23.8	12.7	10.4	9.5	11.3	11.2	9.2
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	22.1	18.6	21.5	13.6	19.0	55.8	7.7	30.8	48.9	18.7	21.5	18.0	24.8	0.5	58.6	52.3	21.2	8.9	19.2	16.5	0.0	8.3	1.4	23.3	15.3	12.6	0.6	4.8	44.8	7.3	16.7	18.1	42.2	7.1	0.0	58.0	78.7	0.0	0.4	17.3	56.1	3.5	22.3	0.1	99.4	17.0	6.6	0.2	66.0	34.0	66.6	27.7	0.8	59.7	12.9	7.2	17.2	37.1	0.2	0.5	1.0	23.1	0.3	7.5	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 656.0;RT4: 256.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"			130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: "	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	24.8	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.2	0.5	61.7	0.0	656.0	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	87.4	0.7	99.7	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.0	4.8	0.0	15.6	0.0	15.5	256.5	0.5	0.0	1.0	0.1	0.2	0.1	0.1	0.1	0.3	21.7	2.9	8.4	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: , HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favourable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	14.8	0.1	0.4	0.3	0.0	4.9	12.7	0.3	0.7	0.0	0.0	0.0	5.7	6.9	0.0	9.2	0.0	0.4	0.0	5.6	0.0	0.0	8.9	0.3	0.0	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	1.8	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	23.5	0.0	4.9	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell line enhanced"	"Detected in all"		"AF22: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: , HPA070248: "	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	7.1	3.6	53.9	11.5	21.0	18.2	7.6	8.0	15.1	5.4	9.6	22.5	26.6	6.7	25.4	8.7	26.7	16.8	20.3	5.3	3.3	22.9	10.0	23.5	17.9	17.1	6.3	3.4	14.9	16.7	17.1	17.6	8.2	6.5	9.8	24.9	7.4	2.5	8.2	16.8	11.4	3.5	13.6	5.7	38.0	32.0	14.2	8.0	18.4	4.2	10.5	16.8	10.9	15.5	5.2	8.4	9.2	3.7	1.8	3.1	9.0	2.0	13.9	9.0	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: "	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favourable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.3	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.3	0.1	3.9	20.0	0.0	0.0	1.2	0.0	0.0	0.0	10.3	0.0	0.0	1.9	0.0	0.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribbled planar cell polarity protein"	Q14160	8	143790920-143815379	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"				"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: , HPA064312: "	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	13.0	6.1	15.1	10.8	12.2	9.4	15.9	10.1	13.9	15.1	18.4	17.5	9.8	14.8	9.4	5.9	36.6	11.6	11.9	8.0	12.2	7.7	10.2	13.6	11.5	12.9	13.5	12.8	10.9	17.2	11.2	9.6	9.5	11.8	10.9	7.6	7.5	22.9	11.2	36.8	33.3	16.3	11.2	9.7	11.2	17.0	10.1	16.4	14.0	9.1	11.9	9.6	11.6	17.8	0.6	0.5	0.2	0.4	0.2	1.5	0.6	18.5	15.0	6.9	8.7	2.5	3.2	11.6	10.4	3.0	4.8	4.0	6.6	12.1	7.3	12.7	3.0	19.4	3.7	14.0	0.9	8.1	20.6	10.2	12.9	11.5	5.7	4.2	5.8	2.7	13.6	4.7	4.0	5.3	12.9	2.6	3.7	36.9	11.0	9.1	5.2	19.0	13.3	6.4	8.2	2.5	18.7	15.0	11.0	11.8	13.0	11.0	16.4	10.2	10.1	5.3	22.2	9.4	14.6	9.2	9.0	7.5	5.5	4.3	8.3	0.1	0.1	0.1	0.6	0.4	1.5	0.6	0.4	1.2	0.5	0.4	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.6	15.1	12.2	10.1	13.9	12.2	7.7	13.5	12.8	11.8	16.4
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.7;HUVEC TERT2: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		290000	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.7	0.8	11.7	4.5	4.9	1.6	1.0	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.1	1.1	0.4	0.7	1.0	3.4	6.1	0.5	0.9	0.6	0.1	2.3	2.8	1.4	1.0	0.5	20.4	0.5	0.6	1.9	0.4	1.0	0.8	5.2	1.3	7.2	2.6	0.2	0.4	0.3	5.9	7.7	1.1	0.5	0.9	1.3	1.0	9.5	2.0	2.8	2.9	0.4	4.9	0.9	5.0	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6
SEPT2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"			8800000	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favourable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	64.2	46.4	76.5	42.9	69.9	29.1	58.7	34.9	61.8	69.3	48.4	85.2	57.4	37.8	59.5	59.8	46.8	48.2	54.0	56.2	65.8	55.4	64.6	31.4	51.2	51.3	76.5	52.7	63.4	73.0	56.6	56.3	58.9	60.7	53.7	53.3	48.8	43.6	64.7	39.5	32.0	42.2	81.8	100.8	51.5	45.6	67.7	57.2	36.2	64.2	39.0	47.5	56.5	42.6	25.5	51.2	38.5	50.5	51.3	36.9	59.4	31.9	28.8	78.5	51.3	73.1	79.8	40.6	70.8	69.8	45.5	58.0	16.1	34.8	13.0	16.9	80.9	28.5	51.2	47.9	74.9	32.8	36.4	52.2	28.8	59.4	44.8	49.7	31.9	71.0	31.4	37.9	36.6	79.2	46.5	19.1	66.9	23.0	29.4	30.4	57.1	21.1	29.1	98.7	27.5	67.5	48.9	56.3	37.9	49.0	33.9	46.7	20.3	44.9	74.8	55.8	23.7	53.8	41.8	37.7	32.8	45.8	48.0	30.4	77.0	38.5	46.0	26.3	30.3	50.5	36.9	25.5	29.6	31.2	51.2	21.6	26.2	27.4	16.3	51.3	37.2	38.6	29.5	59.4	76.5	69.9	34.9	52.3	65.8	55.4	76.5	52.7	60.7	57.2
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"			50000	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: "	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	22.4	35.7	16.9	7.5	19.0	0.6	23.2	23.6	18.5	22.5	20.5	16.8	14.0	5.3	23.6	16.8	11.1	17.1	19.0	19.3	17.7	14.3	12.9	8.9	17.3	9.0	21.5	12.9	59.3	12.9	8.7	23.1	31.9	15.0	15.6	9.7	11.2	11.9	22.7	6.1	3.5	8.0	28.1	20.9	15.8	11.2	13.2	17.5	2.9	15.4	6.9	4.4	22.7	16.1	9.2	0.3	0.6	0.1	1.4	2.9	0.5	3.8	12.0	12.2	19.7	19.4	36.5	2.2	14.5	29.3	12.4	18.8	7.5	22.8	3.6	20.7	25.6	2.5	18.3	6.4	16.9	0.6	9.9	0.3	11.8	8.1	15.2	1.1	0.0	29.4	9.0	18.2	23.8	8.7	0.0	28.8	14.4	12.0	0.0	0.0	9.3	9.5	5.4	15.1	7.6	24.0	3.8	7.7	6.2	0.0	16.1	18.4	5.6	0.1	0.0	39.2	13.1	3.6	22.4	14.9	18.5	4.4	14.6	0.0	22.0	0.6	0.1	0.1	2.9	0.1	1.2	6.4	0.9	1.4	0.1	9.2	0.3	1.0	0.5	1.4	0.1	0.3	0.2	0.5	16.9	19.0	23.6	18.5	17.7	14.3	21.5	12.9	15.0	17.5
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"		10	50305586-50625163	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	14.7	19.6	16.9	12.3	19.4	17.6	13.2	17.5	20.1	15.8	12.8	24.0	11.9	11.7	12.5	18.1	13.7	14.8	13.6	16.6	18.2	14.6	17.9	23.5	18.6	11.6	22.9	14.0	16.9	19.1	64.6	22.9	20.7	18.6	17.6	10.7	15.5	19.8	15.8	13.2	25.6	13.7	15.2	31.7	13.6	12.8	9.6	24.9	11.4	21.5	8.7	14.9	15.2	21.3	5.3	3.7	20.1	6.7	7.6	11.0	4.2	15.8	7.5	2.2	4.9	8.0	10.6	10.4	10.6	10.7	7.5	7.0	6.2	16.5	11.7	6.2	13.9	10.1	5.2	11.1	7.8	10.2	5.5	16.9	10.1	4.8	9.3	3.8	4.2	6.8	13.1	9.9	12.1	10.5	32.5	17.7	8.0	6.7	1.7	2.2	5.0	7.2	2.8	10.2	4.5	10.9	16.8	3.4	2.7	7.7	7.8	4.0	11.7	1.4	14.6	8.1	9.9	7.7	7.7	6.0	4.7	3.3	10.1	6.4	6.6	2.4	6.7	20.1	3.7	3.4	8.2	5.3	4.9	5.4	3.7	5.0	6.8	4.3	12.5	7.6	2.7	2.3	11.0	4.2	16.9	19.4	17.5	20.1	18.2	14.6	22.9	14.0	18.6	24.9
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638097-65650930	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"				Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: "	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	10.5	9.1	7.5	27.1	12.0	29.8	10.0	2.6	8.7	8.9	10.8	9.4	2.9	7.7	10.9	3.0	7.6	9.0	9.9	8.0	8.4	4.6	9.5	7.8	17.6	33.2	11.5	4.7	7.7	4.6	2.7	4.2	11.9	10.3	8.6	3.9	8.2	8.7	6.8	5.4	4.2	17.2	9.0	14.3	47.1	8.1	3.0	10.5	25.3	7.7	4.6	32.7	8.5	7.8	6.6	2.8	14.1	5.2	5.8	7.4	3.0	0.7	6.2	4.4	9.5	2.6	5.4	10.5	7.1	6.0	5.5	5.4	1.9	6.8	9.8	16.0	3.5	3.6	1.6	2.3	1.8	10.6	3.9	23.9	9.1	3.3	4.6	9.6	10.3	5.5	1.1	7.7	1.0	16.2	13.5	4.5	2.7	2.7	3.8	16.5	3.0	5.7	17.5	2.4	8.7	2.1	0.5	1.7	10.1	3.5	6.1	14.5	4.6	14.9	22.7	6.9	13.9	7.5	1.4	6.8	5.3	22.0	9.4	15.4	19.8	4.0	4.1	10.2	7.4	4.8	5.5	5.3	3.7	4.8	2.8	6.6	2.9	4.4	14.1	5.8	5.2	2.7	3.5	3.0	7.5	12.0	2.6	8.7	8.4	4.6	11.5	4.7	10.3	10.5
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: , HPA067637: "	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.7	1.4	0.0	0.1	3.8	0.0	0.3	1.4	0.0	18.9	9.8	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.7	0.0	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Group enriched"	"Detected in some"	12	"HEL: 6.6;U-937: 4.3"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"				"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: , HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.2	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in some"	81	"BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037989	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus"	"HPA037989: AB_10670536"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.1"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: , HPA052726: "	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	10.1	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.0;SCLC-21H: 7.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: "	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.2	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.0	0.1	1.2	0.2	0.0	0.2	7.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.1	7.0	2.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	10.6	10.0	8.6	13.8	9.6	4.8	11.0	16.3	11.8	9.9	10.8	9.6	9.6	11.5	15.3	8.7	6.3	10.1	7.1	11.0	6.3	6.1	6.1	7.4	8.5	10.4	7.4	6.7	15.5	21.7	5.4	11.3	7.7	9.2	10.1	8.3	10.7	14.1	15.5	19.3	10.6	12.9	10.0	9.2	10.0	7.6	9.2	8.2	12.8	9.1	5.6	12.2	10.8	12.8	6.1	6.3	11.5	4.3	4.1	7.9	3.0	6.0	11.3	11.4	8.1	7.8	5.4	13.3	9.8	5.7	10.5	10.8	18.0	5.2	16.1	6.7	4.0	11.7	10.8	6.4	13.1	4.6	10.9	5.9	12.0	4.8	3.9	5.9	5.8	3.8	5.8	10.7	9.5	5.1	6.1	6.3	8.1	3.7	10.9	4.2	5.2	5.6	13.5	5.8	4.1	4.2	7.3	4.7	6.5	9.1	3.8	9.4	5.5	3.7	5.0	10.3	5.3	8.6	8.5	4.4	5.9	5.8	5.8	5.3	10.0	11.5	3.6	3.2	7.9	4.3	6.5	6.1	4.6	5.0	2.1	3.8	5.3	7.6	2.1	4.1	3.3	6.3	4.8	3.0	8.6	9.6	16.3	11.8	6.3	6.1	7.4	6.7	9.2	8.2
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 50.8;TIME: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favourable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favourable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.2	2.0	3.7	3.5	11.1	4.0	3.5	3.5	5.9	3.8	3.8	2.7	4.7	5.1	2.8	4.4	2.1	4.3	7.5	4.0	5.9	3.5	5.9	3.7	3.1	5.8	6.6	6.6	4.4	5.2	4.3	7.4	50.8	2.6	6.0	3.5	1.7	6.6	5.8	4.1	9.1	4.6	2.7	5.4	9.9	5.6	2.6	5.5	3.0	3.3	4.2	2.2	8.4	29.5	3.4	3.4	3.9	4.1	9.7	6.9	4.4	2.4	7.9	4.8	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: , HPA074049: "	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20009344-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	10.7	8.3	21.3	7.2	38.0	29.9	8.1	16.0	30.8	7.0	14.9	49.9	0.7	9.5	15.4	6.1	11.4	7.3	20.0	4.1	23.1	15.4	4.3	2.0	5.6	5.7	35.8	21.2	17.0	8.3	3.0	6.8	4.8	29.3	7.3	15.5	3.0	5.9	4.9	4.3	4.8	11.4	11.5	28.2	17.3	9.8	25.8	41.5	0.2	6.7	1.4	6.0	7.0	4.2	2.9	14.7	18.9	9.4	8.5	3.4	3.0	17.2	18.0	9.8	3.2	7.4	3.8	21.1	7.0	5.8	7.1	8.8	29.3	15.4	1.0	22.9	6.0	12.9	7.4	16.7	3.5	5.2	7.9	7.1	19.7	3.2	2.7	0.7	4.2	4.0	17.0	10.0	11.3	0.1	0.8	8.7	5.5	14.7	0.2	3.9	7.8	4.3	4.2	19.7	9.9	17.3	8.7	3.2	3.2	36.8	17.7	7.8	15.6	4.6	0.5	0.9	10.8	1.0	19.0	3.4	4.3	1.4	10.4	5.9	4.1	18.9	9.4	17.8	3.1	5.3	2.9	2.4	1.9	3.4	14.7	2.9	1.8	2.4	8.1	8.5	4.6	4.4	0.9	3.0	21.3	38.0	16.0	30.8	23.1	15.4	35.8	21.2	29.3	41.5
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962689-14267884	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.2"	"Group enriched"	"Detected in some"	35	"EFO-21: 41.0;RPTEC TERT1: 115.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 199.1"					"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"T-cells: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	11500000	27000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: "	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (1.88e-4)"	16.8	5.1	8.3	5.2	12.5	0.0	3.3	4.8	10.7	15.7	9.7	7.6	0.0	9.6	12.0	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12.0	0.8	0.0	2.0	12.3	7.5	7.2	15.0	8.5	0.9	2.5	0.0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0.0	0.8	0.6	0.0	15.6	9.9	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	115.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	0.0	1.3	0.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3										
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023265-132075943	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: "	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	5.4	1.4	1.1	13.5	5.1	25.9	3.3	3.8	1.1	18.0	6.4	0.3	34.8	3.7	42.3	29.6	11.7	6.0	5.2	1.9	1.2	2.3	3.5	3.2	6.7	12.8	1.2	0.3	4.7	4.0	10.2	5.8	50.7	1.2	11.5	4.8	2.2	6.3	22.4	1.2	5.1	6.1	19.1	1.5	8.5	4.7	5.2	0.8	44.7	2.3	6.8	10.2	18.0	6.6	8.4	6.2	26.4	11.6	22.0	13.3	10.2	9.0	3.1	0.3	0.0	1.5	1.4	20.7	0.3	1.1	0.1	0.1	8.3	8.2	12.3	5.6	2.0	10.3	23.0	14.4	0.0	10.6	18.8	17.7	7.8	7.8	1.4	37.0	1.4	2.0	8.6	0.0	9.8	4.0	7.8	11.6	3.4	7.9	38.0	34.4	18.4	1.2	27.5	11.4	15.8	9.3	14.5	7.7	8.5	5.4	4.9	0.2	6.3	9.8	0.1	3.7	4.0	11.2	13.2	8.9	14.0	13.7	3.4	40.3	1.8	26.4	5.1	16.6	13.3	6.7	13.0	8.4	9.1	11.3	6.2	7.3	11.8	12.2	10.0	22.0	11.6	2.3	4.0	10.2	1.1	5.1	3.8	1.1	1.2	2.3	1.2	0.3	1.2	0.8
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin-like modifier 1"	P63165	2	202206180-202238608	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: "	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favourable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	27.1	37.8	44.4	21.6	37.9	41.8	31.6	47.7	49.2	26.9	29.7	19.9	27.2	26.2	24.7	33.4	26.9	24.7	26.6	28.3	38.0	39.6	43.5	62.6	24.6	28.7	34.6	40.6	23.4	29.8	26.6	28.7	30.4	32.3	28.8	31.2	21.6	35.6	24.5	42.4	21.6	33.2	27.6	29.6	25.1	26.4	28.7	27.1	32.2	38.4	28.1	33.6	26.9	23.1	74.8	63.0	77.0	63.7	65.8	89.0	94.0	33.6	17.1	62.3	33.1	34.7	37.1	27.8	35.9	45.3	44.8	59.4	36.8	42.9	23.0	33.3	41.3	24.7	51.0	49.8	70.4	21.5	39.1	42.6	33.6	43.1	25.1	48.0	40.6	28.5	48.2	35.0	26.7	41.6	39.2	37.6	47.8	28.6	60.4	79.9	74.9	36.3	39.2	34.9	40.6	54.2	28.0	43.4	47.3	29.3	28.4	47.9	25.5	46.0	29.1	33.1	33.3	30.2	31.6	32.8	64.5	58.5	36.8	34.2	28.9	56.6	63.7	77.0	51.1	62.6	53.5	74.8	63.7	59.8	63.0	58.4	60.2	62.8	73.6	65.8	62.8	52.9	89.0	94.0	44.4	37.9	47.7	49.2	38.0	39.6	34.6	40.6	32.3	27.1
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"				Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: , HPA060385: "	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	13.9	10.6	12.5	19.9	18.4	14.2	12.9	17.3	20.1	15.1	14.7	4.3	17.3	16.8	15.2	9.7	16.0	11.5	18.1	11.1	12.0	7.6	13.6	18.7	15.8	19.0	14.4	13.6	20.9	30.5	9.3	24.3	18.5	13.6	16.4	13.4	3.9	12.3	11.4	31.5	14.5	17.8	18.1	22.1	18.4	13.0	8.0	13.6	13.1	13.2	12.9	12.2	28.1	17.1	24.1	14.3	22.3	9.2	9.0	16.3	2.7	3.8	3.0	4.1	4.1	4.1	16.0	7.5	4.4	3.2	5.6	4.0	10.5	10.6	9.4	8.4	4.2	11.6	4.8	6.9	6.2	2.5	2.0	9.6	17.3	6.2	4.0	8.7	5.2	4.4	7.4	4.5	7.3	7.0	6.5	18.6	7.7	1.2	7.3	16.8	3.2	2.4	3.5	4.7	8.0	6.5	6.2	2.9	6.2	2.6	9.5	3.0	11.8	2.2	6.8	8.4	5.6	12.7	6.4	8.3	9.4	7.9	3.1	9.3	2.8	17.4	9.2	14.8	10.0	6.5	10.0	19.5	13.8	10.9	6.2	24.1	16.3	13.6	22.3	9.0	5.2	14.3	9.4	2.7	12.5	18.4	17.3	20.1	12.0	7.6	14.4	13.6	13.6	13.6
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	11.9	0.7	0.2	2.8	18.9	0.0	0.0	1.4	0.5	0.1	2.1	4.0	0.8	0.3	2.8	1.4	2.4	2.4	0.3	6.5	18.3	0.3	0.1	0.3	0.0	16.0	1.2	0.8	8.1	3.2	0.0	0.0	6.0	6.0	7.7	2.8	0.1	3.8	5.1	3.6	3.7	0.0	1.8	19.0	17.9	4.4	0.8	6.2	0.7	2.5	0.0	0.1	1.7	6.9	0.0	0.8	6.7	5.0	3.6	4.0	1.4	13.1	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Predicted membrane proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;kidney: 8.8"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 30.9"	"Group enriched"	"Detected in some"	8	"glioma: 7.6;renal cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 1.4;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"			140000	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: "	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.4	0.5	4.9	0.4	4.1	0.2	0.3	17.3	8.7	1.2	0.4	1.7	0.3	4.9	0.6	0.5	0.4	0.4	0.8	0.5	2.9	5.1	8.8	1.3	0.4	0.7	4.5	2.8	0.5	0.2	0.3	0.0	0.9	5.3	0.4	0.5	0.0	0.8	0.8	0.3	0.8	2.8	0.6	20.0	0.7	0.6	2.4	2.2	0.0	0.4	0.0	0.6	0.7	0.1	0.0	0.0	0.0	0.0	1.4	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	3.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.4	0.5	0.0	0.0	2.6	1.8	0.0	1.4	0.0	0.0	0.0	0.4	4.9	4.1	17.3	6.9	2.9	5.1	4.5	2.8	5.3	2.2
TMEM62	FLJ23375	ENSG00000137842	"Transmembrane protein 62"	Q0P6H9	15	43123279-43185146	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044461, HPA062359"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies"				"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies"		"HPA044461: , HPA062359: "	"unprognostic (7.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.56e-2)"	"prognostic favourable (9.72e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	11.6	8.6	7.6	9.5	12.0	9.6	28.6	21.1	13.9	10.4	15.5	15.1	9.8	15.5	9.9	15.4	10.7	9.4	14.0	7.3	7.8	9.8	9.5	12.3	13.0	10.5	10.2	8.2	6.1	12.0	16.5	10.8	12.3	12.7	8.6	17.6	11.9	16.9	9.2	14.5	8.5	17.3	11.0	11.9	9.6	12.0	3.1	7.8	4.6	10.5	8.9	13.7	13.2	9.0	2.5	4.6	2.6	1.8	3.8	5.0	0.9	7.4	4.0	1.8	3.5	2.2	3.0	19.3	7.2	9.1	12.9	17.9	6.4	14.8	7.6	4.2	6.8	14.4	7.7	5.7	4.7	8.9	3.4	6.2	8.9	4.7	5.0	6.4	5.6	2.1	6.8	5.6	3.9	7.0	5.4	6.6	1.4	1.7	0.0	1.5	0.6	1.7	3.8	2.0	4.0	6.8	9.5	11.7	5.0	5.7	14.2	3.4	7.6	6.5	4.1	6.4	2.6	4.5	11.6	5.5	33.2	5.4	5.9	7.1	5.5	1.5	1.8	2.6	2.4	0.8	2.9	1.9	3.2	2.7	2.0	2.5	1.9	2.6	0.5	3.8	1.0	4.6	5.0	0.9	7.6	12.0	21.1	13.9	7.8	9.8	10.2	8.2	12.7	7.8
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103123442-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RT4: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 25.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: "	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (4.10e-4)"	"prognostic favourable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favourable (7.17e-5)"	27.3	17.0	3.8	58.2	5.7	20.1	19.3	2.5	3.6	23.5	12.9	2.8	4.7	8.1	16.7	18.7	35.5	14.3	30.9	12.7	2.9	3.6	18.8	13.6	32.0	17.9	4.6	3.0	9.7	9.0	17.4	3.5	33.0	6.1	21.7	6.1	16.3	25.1	7.1	12.5	13.2	11.3	28.0	3.8	35.9	8.3	13.0	2.9	11.0	8.5	31.4	48.6	39.8	16.3	0.1	5.0	25.9	9.8	0.1	0.1	1.9	5.4	26.9	0.1	0.1	1.7	7.7	9.0	1.6	6.9	4.3	1.5	0.2	24.4	0.0	20.1	7.8	17.4	1.9	0.0	2.1	0.9	0.1	2.4	18.8	0.1	3.3	1.2	3.4	2.9	0.2	1.4	0.0	2.2	2.4	5.9	0.6	0.5	0.0	1.9	1.6	2.2	1.0	3.1	3.9	13.8	126.5	0.2	0.3	24.7	8.6	0.3	13.9	8.0	4.6	0.9	2.3	5.0	5.0	5.3	0.3	0.1	6.5	5.5	2.6	2.5	8.8	4.6	0.0	9.8	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	25.9	0.1	6.9	0.2	0.0	1.9	3.8	5.7	2.5	3.6	2.9	3.6	4.6	3.0	6.1	2.9
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.5	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.2	2.1	0.0	2.9	0.0	3.1	0.4	3.6	0.0	19.7	1.4	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.1	3.1	0.0	0.0	0.0	1.6	0.0	7.8	1.0	5.3	0.6	0.2	19.3	0.8	0.5	3.8	5.2	0.0	1.9	0.1	1.6	2.1	1.6	1.0	1.5	0.0	1.5	0.0	3.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.6"					"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"				"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: , HPA024251: "	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	17.9	11.8	18.1	17.9	17.2	29.4	20.6	35.1	23.6	35.0	29.9	16.7	17.9	16.4	36.0	19.5	19.6	27.5	29.2	13.6	14.2	9.6	15.6	11.8	19.2	12.9	15.5	16.7	30.3	18.4	36.9	14.7	19.7	13.2	25.4	15.1	25.2	17.0	24.4	13.6	18.9	16.9	40.1	12.6	15.3	21.4	14.0	16.6	7.2	20.6	12.8	9.4	27.0	21.4	2.0	4.3	17.6	3.2	2.6	1.5	0.1	21.3	19.1	15.9	13.3	13.4	16.0	41.1	15.2	14.4	8.4	9.0	7.8	18.8	14.6	15.0	22.2	23.9	9.1	18.2	7.1	6.4	5.8	9.3	16.3	12.7	11.7	30.5	34.3	16.1	21.5	16.8	19.6	9.5	13.1	8.3	10.7	35.5	7.1	37.3	1.4	14.6	8.0	7.9	10.8	6.9	27.3	6.9	16.6	11.8	31.3	11.3	32.7	31.6	23.6	24.5	34.5	14.5	10.9	11.9	12.3	13.8	13.7	21.7	28.5	9.4	3.2	2.7	1.4	1.2	1.0	1.6	1.0	0.8	1.1	2.0	0.7	1.5	17.6	2.6	1.5	4.3	1.4	0.1	18.1	17.2	35.1	23.6	14.2	9.6	15.5	16.7	13.2	16.6
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"				"Nucleoli, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA047601: , HPA058241: "	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.6	4.7	9.2	4.7	5.5	7.7	6.7	8.1	3.1	5.7	4.3	3.9	8.3	9.2	3.1	4.8	3.9	10.7	5.1	8.8	11.7	4.7	6.3	4.1	6.4	5.2	16.0	6.8	4.9	13.2	5.7	12.5	5.8	14.6	8.3	4.8	7.7	13.5	3.3	5.5	4.6	7.8	8.8	5.9	7.7	5.5	5.8	5.0	4.4	24.6	8.1	8.0	6.9	4.2	5.8	6.0	4.7	9.2	5.8	9.7	8.4	4.4	9.4	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150497	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavourable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	13.0	12.2	13.9	21.7	24.1	5.9	18.3	26.5	22.5	17.4	13.1	18.2	24.2	13.6	17.4	15.4	13.7	13.9	9.6	12.0	14.4	9.0	12.1	13.0	9.6	20.9	23.1	12.8	21.4	18.1	23.8	26.8	13.2	15.6	14.9	14.4	10.8	14.3	17.4	16.9	17.9	14.2	14.3	19.4	16.5	12.6	11.1	25.8	17.8	16.5	12.0	17.6	13.9	15.8	15.1	9.6	2.2	4.5	5.4	13.6	3.9	10.6	6.2	10.5	7.3	5.7	11.2	11.5	11.3	4.5	8.6	7.2	7.4	4.4	17.6	14.1	9.0	9.7	19.3	8.7	15.0	17.7	15.3	10.5	13.8	7.1	10.3	18.1	9.9	7.8	10.0	16.3	21.5	7.8	22.0	11.4	8.6	4.0	14.8	9.6	14.6	12.6	15.9	15.9	9.6	7.1	8.5	6.9	11.5	10.4	10.0	13.3	5.9	16.1	8.1	11.5	7.7	9.6	15.0	14.6	11.8	20.9	13.0	14.6	4.4	0.1	4.5	2.2	8.5	4.4	10.4	14.8	9.0	8.3	5.2	15.1	13.6	11.1	1.9	5.4	3.5	9.6	6.2	3.9	13.9	24.1	26.5	22.5	14.4	9.0	23.1	12.8	15.6	25.8
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750211	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 59.0"	"Cancer enhanced"	"Detected in all"		"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: "	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favourable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	27.0	26.4	19.4	18.2	22.5	5.4	21.8	14.3	20.5	21.9	20.1	30.5	23.0	16.3	23.1	37.6	21.3	27.7	23.3	23.3	19.1	17.8	32.1	29.2	20.7	14.5	20.3	16.0	32.0	32.1	31.4	22.7	31.5	19.4	23.3	19.0	32.1	24.6	22.0	19.8	15.2	24.0	17.5	24.3	23.1	18.2	11.4	17.1	14.6	42.4	16.5	20.7	20.2	16.8	17.6	35.4	18.6	24.8	23.7	22.0	18.8	3.5	8.7	8.9	2.2	20.7	13.6	5.8	5.6	7.5	3.0	3.0	6.0	19.2	3.2	12.6	13.0	7.4	2.3	12.0	4.3	8.5	6.3	4.4	7.2	2.5	20.4	4.3	7.6	12.0	14.2	5.9	12.5	8.0	3.1	9.4	9.8	7.2	3.3	2.5	1.9	2.8	4.2	59.0	8.4	12.5	7.3	3.1	7.6	6.1	8.9	4.4	16.8	6.8	10.9	4.9	4.1	2.6	3.0	11.7	2.6	1.5	13.3	2.9	7.4	18.6	15.7	11.1	22.0	15.7	21.3	17.6	17.8	18.9	15.6	16.8	17.8	16.7	5.3	23.7	24.8	35.4	12.1	18.8	19.4	22.5	14.3	18.5	19.1	17.8	20.3	16.0	19.4	17.1
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.4	26.2	19.2	17.4	17.3	12.5	17.1	20.3	16.5	18.9	16.3	24.7	22.4	22.4	14.1	17.7	21.2	46.9	28.1	25.3	29.1	23.2	18.2	19.6	19.2	10.7	31.5	19.1	11.6	15.4	26.4	27.3	13.2	18.5	16.8	19.2	37.5	24.0	24.8	30.5	29.8	21.6	35.7	18.9	20.1	18.2	24.2	16.8	38.6	19.3	21.5	39.3	11.0	17.9	13.9	24.5	29.2	17.3	18.0	27.1	26.8	20.5	25.1	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"			9600	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: , HPA065335: "	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	19.1	25.3	29.7	22.2	31.0	53.7	26.8	30.9	31.4	20.3	19.7	31.3	15.9	16.1	22.8	25.4	25.4	19.5	18.4	38.2	23.8	22.7	24.7	17.6	19.3	28.7	37.5	21.2	20.4	15.1	17.9	28.0	27.8	40.8	22.6	22.6	21.8	28.0	20.4	25.0	27.6	21.9	24.0	30.2	27.8	17.3	13.5	31.9	28.4	18.2	17.2	31.0	22.9	20.4	18.9	22.3	35.6	27.8	20.2	22.2	26.0	26.8	11.4	28.1	17.1	26.3	34.9	21.7	24.1	27.3	26.3	26.5	14.1	19.0	20.5	7.0	25.9	15.5	21.6	27.6	30.0	37.3	13.7	27.7	21.5	14.2	20.3	27.1	23.3	27.4	18.5	24.8	20.8	33.8	11.4	17.6	34.6	9.6	17.8	18.3	24.9	9.8	13.9	20.8	18.8	41.9	34.4	12.1	16.9	25.4	18.5	20.6	12.6	26.7	25.6	20.0	17.6	25.9	33.4	20.2	32.3	24.4	20.5	30.2	25.4	34.7	25.4	35.6	14.3	27.8	16.1	18.9	18.9	17.6	22.3	16.0	17.9	18.0	24.4	20.2	27.7	11.4	22.2	26.0	29.7	31.0	30.9	31.4	23.8	22.7	37.5	21.2	40.8	31.9
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: , HPA049132: , HPA056624: "	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	84.7	73.8	71.1	76.4	76.5	167.0	101.5	32.8	71.1	83.2	73.0	48.7	67.8	47.7	79.0	93.2	102.7	78.8	82.0	85.9	58.2	50.2	74.1	135.5	67.7	182.7	64.0	59.0	150.3	225.2	56.5	62.8	71.6	55.5	75.8	74.0	51.6	96.0	75.2	191.4	104.6	68.0	91.9	72.0	101.1	75.5	89.5	52.1	121.2	97.6	131.7	145.1	99.9	161.7	200.5	157.0	75.1	132.4	109.7	205.0	246.6	104.6	83.7	62.9	104.8	163.3	155.4	155.9	80.9	112.4	134.4	107.3	151.5	98.2	151.9	83.7	133.3	71.0	121.5	143.8	127.2	40.7	189.8	83.1	130.1	170.8	119.0	180.2	106.5	179.8	196.8	92.1	134.0	134.6	131.4	210.6	114.6	175.3	143.9	161.7	140.7	181.3	119.1	62.8	173.8	129.5	159.2	82.0	99.2	58.7	142.4	140.2	63.1	233.3	99.9	67.5	56.4	142.0	142.9	129.7	172.1	150.3	91.8	204.8	91.3	50.7	132.4	69.8	119.4	107.2	162.2	200.5	178.5	142.6	147.6	199.1	205.0	165.6	75.1	109.7	96.1	157.0	138.5	246.6	71.1	76.5	32.8	71.1	58.2	50.2	64.0	59.0	55.5	52.1
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (2.27e-3)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	32.5	27.5	17.3	14.6	30.3	37.4	16.2	33.8	30.2	40.3	38.3	14.2	22.4	25.8	34.4	37.2	23.5	24.7	17.9	38.9	35.8	14.6	11.4	22.0	12.7	27.8	28.5	19.6	25.5	25.6	38.6	16.8	27.9	14.0	23.1	45.6	34.5	43.9	26.9	28.8	31.1	22.4	18.4	24.0	32.5	21.4	13.3	13.7	45.0	20.7	24.6	18.0	24.9	27.2	25.9	11.6	51.1	38.1	22.4	36.4	25.3	27.5	36.1	20.2	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	36.2	9.6	20.0	19.0	17.5	18.9	32.3	27.3	14.4	17.6	21.0	28.9	24.4	19.8	33.0	17.4	14.5	15.1	20.2	19.2	31.4	16.3	10.9	26.5	31.0	20.5	12.9	22.4	16.2	27.5	15.9	13.5	15.0	19.9	36.0	15.8	21.2	20.4	34.1	8.6	9.1	20.6	22.0	27.6	15.7	28.1	27.0	21.1	21.4	10.1	47.4	21.8	35.6	29.7	20.5	14.3	27.5	29.8	30.1	41.2	27.9	23.1	24.4	20.3	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7
UNC13B	"hmunc13, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"				Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: "	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favourable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favourable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favourable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favourable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	11.9	12.1	9.3	9.0	18.3	1.4	10.4	16.6	18.8	12.2	21.4	10.1	35.0	11.5	10.6	8.4	14.9	11.1	14.6	11.1	9.2	7.1	22.1	21.5	37.6	2.2	9.5	9.5	7.9	28.7	21.7	13.7	6.3	10.1	20.5	25.1	27.2	20.7	33.6	21.1	14.6	13.0	12.2	9.4	5.0	15.8	16.2	9.1	0.8	12.5	11.6	5.8	8.6	10.4	0.9	1.9	0.0	0.4	0.0	0.3	0.4	5.4	7.3	8.1	13.0	15.7	8.8	6.9	8.9	4.1	6.6	9.0	6.0	2.5	0.0	4.1	11.6	2.6	20.4	10.4	8.5	0.0	6.5	3.3	20.7	7.7	7.6	1.2	3.8	6.9	8.2	10.5	10.9	21.4	7.4	4.7	7.8	4.2	1.1	0.1	7.3	7.7	0.0	5.0	1.9	9.1	7.1	8.7	9.2	6.3	3.9	6.5	6.7	4.2	19.6	4.6	4.3	7.1	6.8	7.4	8.8	0.0	5.0	10.4	4.6	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.3	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	9.3	18.3	16.6	18.8	9.2	7.1	9.5	9.5	10.1	9.1
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: "	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavourable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	38.8	34.7	47.1	35.3	21.4	28.7	34.7	43.0	27.7	45.2	38.8	46.1	29.2	57.0	30.1	29.4	33.0	71.8	29.8	66.7	34.8	26.4	56.1	35.8	28.8	15.5	56.5	38.4	16.2	22.3	35.7	39.0	36.9	64.7	33.3	41.6	20.4	47.0	24.8	54.8	26.6	42.1	53.8	34.6	20.6	29.5	37.7	20.0	41.8	35.4	20.9	28.9	27.9	24.6	42.5	48.3	34.6	42.2	27.0	44.6	82.7	26.4	48.5	38.3	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.4	20.4	18.0	19.3	12.5	19.9	20.7	35.2	31.9	41.3	41.8	28.6	20.4	20.2	30.4	32.0	18.6	42.7	27.0	50.2	45.5	26.5	22.1	28.8	31.8	29.6	30.8	24.9	15.6	20.1	36.6	36.3	23.7	40.2	10.2	27.9	31.9	37.0	36.8	30.5	19.5	34.8	21.4	33.5	15.3	14.5	35.2	19.1	17.4	29.1	15.4	20.9	20.4	25.1	34.9	23.4	29.7	29.3	23.9	30.2	30.0	26.6	32.2	29.4	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158159-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"				"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: , HPA073622: "	"prognostic unfavourable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.12e-5)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	26.6	26.6	18.4	14.7	21.2	15.8	22.5	19.2	22.6	23.9	22.2	17.2	22.5	26.5	25.7	22.0	27.2	18.9	19.0	18.3	15.1	18.5	23.0	27.8	20.4	21.0	16.2	20.5	19.6	41.7	21.5	45.3	37.1	21.8	16.8	23.4	18.9	32.7	18.3	11.9	24.5	30.5	25.2	19.7	18.8	23.8	20.7	16.2	14.0	20.2	21.2	20.1	24.1	19.9	22.3	27.2	28.8	28.1	23.7	36.7	23.4	11.4	7.7	10.0	7.9	24.0	26.0	9.1	39.2	26.6	17.7	28.6	12.2	12.1	6.3	18.9	42.5	10.6	9.5	19.2	23.9	8.8	8.3	4.6	13.4	12.4	19.4	10.3	7.7	19.6	18.0	15.8	13.0	16.7	4.9	10.6	23.8	6.0	5.0	5.9	6.4	8.4	5.4	14.9	10.4	11.0	10.2	6.8	8.4	13.6	7.3	17.4	15.2	6.8	64.4	20.9	10.1	20.1	15.4	9.7	15.9	8.0	19.9	9.9	15.1	25.6	21.0	28.8	30.3	28.1	34.3	22.3	31.0	33.6	25.0	21.5	32.8	30.8	15.6	23.7	25.4	27.2	36.7	23.4	18.4	21.2	19.2	22.6	15.1	18.5	16.2	20.5	21.8	16.2
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997510	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favourable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favourable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	8.3	6.8	8.2	7.0	13.9	15.7	9.6	9.4	15.5	8.5	7.2	13.2	3.5	6.4	14.1	9.5	8.8	7.5	7.2	7.3	9.0	8.7	6.5	13.2	6.2	10.5	9.9	9.8	10.4	7.8	8.4	11.8	5.1	14.5	9.8	9.2	12.5	9.0	7.1	8.2	12.8	8.2	7.8	10.8	12.3	6.2	15.5	9.2	15.6	8.4	14.3	10.2	7.7	7.6	9.1	8.8	19.6	7.6	7.0	11.2	5.6	3.1	6.6	7.0	10.5	13.3	11.8	3.7	4.6	8.1	6.0	6.5	3.0	5.4	10.8	6.9	5.0	6.6	5.8	7.2	6.6	8.1	4.9	6.4	6.7	4.2	9.4	3.7	8.6	9.7	11.8	4.6	8.4	9.1	3.7	5.1	8.2	3.3	11.8	7.2	5.2	3.0	9.9	7.1	4.8	8.7	3.9	2.7	5.9	7.8	3.9	6.1	5.5	3.4	7.1	7.2	3.6	3.2	3.5	5.7	4.1	5.3	8.3	8.3	8.4	10.6	5.9	6.6	11.0	5.8	10.2	9.1	10.2	10.3	5.8	8.2	11.0	11.2	19.6	7.0	7.6	8.8	10.6	5.6	8.2	13.9	9.4	15.5	9.0	8.7	9.9	9.8	14.5	9.2
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142805	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: "	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	5.7	8.2	9.0	6.0	10.3	6.0	5.7	10.8	16.7	5.0	6.2	14.6	4.7	9.3	7.5	5.1	8.4	6.8	6.0	9.1	9.5	7.7	4.4	2.4	6.3	8.8	7.1	9.3	10.3	12.1	8.7	7.3	4.1	9.1	6.5	2.5	6.8	17.4	5.9	11.1	16.9	11.2	6.8	7.6	7.5	6.9	20.1	8.0	7.5	9.2	4.7	5.4	7.1	5.8	4.8	3.2	3.5	2.5	4.0	4.7	1.8	3.3	10.6	4.7	11.2	4.6	3.8	5.9	6.2	2.5	3.3	3.8	3.4	7.0	4.1	6.1	4.0	8.2	2.2	6.8	1.3	8.5	8.2	2.9	11.7	6.6	8.8	7.0	7.6	3.7	8.5	4.6	1.7	2.4	7.4	9.2	2.1	14.5	6.5	8.6	8.1	8.1	8.8	5.5	7.5	2.6	2.3	9.8	8.5	9.3	5.6	4.4	7.3	12.1	6.0	6.7	6.1	7.5	4.3	5.2	4.8	6.3	2.7	9.3	5.1	0.0	1.6	3.4	3.7	2.5	3.2	2.7	3.6	2.4	1.6	4.8	4.7	3.4	3.5	4.0	1.9	3.2	2.0	1.8	9.0	10.3	10.8	16.7	9.5	7.7	7.1	9.3	9.1	8.0
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740903	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.7	9.8	9.0	18.6	13.1	25.5	7.9	20.2	12.3	10.8	11.1	30.6	9.4	16.0	9.0	8.4	14.5	11.4	9.5	6.7	9.8	7.3	8.4	10.1	9.6	21.7	21.3	11.2	13.5	10.9	11.0	11.6	7.4	12.6	10.2	8.8	8.1	11.3	11.4	11.4	18.5	15.3	6.8	9.9	22.2	12.2	6.4	18.4	11.1	10.1	8.1	15.1	9.5	10.3	2.9	2.0	4.5	1.9	5.0	10.1	2.4	5.0	4.2	3.4	8.9	2.8	3.9	6.1	3.4	2.1	3.2	1.2	5.4	5.3	6.6	4.4	3.6	9.2	4.3	3.8	2.3	4.1	23.2	5.9	7.9	2.1	5.4	5.7	7.8	5.3	5.1	4.3	3.5	4.8	10.8	5.7	1.4	7.0	7.3	13.1	2.5	9.5	11.7	3.8	4.4	4.0	2.9	9.3	7.8	7.5	6.8	4.2	9.2	8.3	5.4	5.3	7.2	4.1	2.9	20.5	6.6	3.5	4.2	9.5	5.2	4.3	1.7	2.8	10.1	1.9	4.8	2.0	5.5	7.6	1.8	2.9	5.6	7.2	4.5	5.0	1.2	2.0	4.0	2.4	9.0	13.1	20.2	11.3	9.8	7.3	21.3	11.2	12.6	18.4
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630181-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	16.5	15.7	10.5	9.2	13.3	22.8	16.5	23.0	18.8	21.1	14.3	14.2	12.6	8.1	21.2	9.0	12.0	18.2	9.9	11.4	10.3	7.0	11.0	14.0	11.4	9.8	11.3	14.9	27.2	16.9	14.4	28.0	12.2	16.9	18.1	12.4	8.5	18.8	11.7	22.0	9.8	11.2	24.8	16.3	11.1	14.6	8.4	14.5	46.3	13.6	8.4	10.0	23.6	19.6	6.1	5.9	10.0	4.1	3.0	4.3	1.8	8.7	5.0	9.2	14.1	9.3	13.1	6.8	13.5	9.6	5.7	6.5	3.5	9.1	14.8	5.7	9.5	6.5	4.6	3.6	6.8	7.5	2.7	1.5	8.2	5.4	9.3	13.2	4.5	8.5	4.9	3.9	5.5	12.3	7.6	17.2	8.6	6.2	8.8	1.5	0.0	4.0	2.8	15.2	10.5	6.6	10.2	7.4	13.5	11.3	7.0	4.3	7.7	12.3	10.8	8.3	12.6	7.6	10.8	9.0	13.5	0.0	9.3	19.7	8.9	10.0	4.1	5.4	3.6	3.7	3.6	6.1	3.4	3.1	5.9	5.5	3.5	4.3	0.6	3.0	3.2	5.9	3.0	1.8	10.5	13.3	23.0	18.8	10.3	7.0	11.3	14.9	16.9	14.5
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA036514: , HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	14.3	10.8	18.3	12.1	19.4	28.8	14.8	20.5	20.3	12.6	19.5	14.5	9.5	15.5	14.4	16.9	13.6	13.2	12.3	38.6	13.8	14.6	14.8	18.8	12.8	14.5	16.8	15.5	15.1	45.9	12.5	15.0	16.0	17.2	13.1	19.8	10.9	17.5	12.8	29.0	18.6	19.6	12.6	12.8	12.4	15.9	14.1	17.3	14.0	16.7	11.9	15.4	13.7	14.9	50.4	45.6	55.4	45.9	39.1	56.9	47.2	11.0	24.2	7.6	15.6	18.6	15.9	27.6	19.9	15.1	16.3	20.8	28.7	10.3	13.0	26.9	15.7	14.6	12.2	15.5	13.1	17.4	16.5	11.8	42.9	20.5	26.8	22.9	14.2	24.5	19.7	15.1	14.3	11.3	15.9	12.9	17.8	18.6	12.0	22.4	13.4	23.9	9.5	9.2	11.0	15.0	16.6	10.5	11.8	27.8	20.9	32.2	11.6	17.8	15.4	18.2	13.9	17.6	12.6	18.6	16.6	18.1	15.8	19.9	12.6	45.2	41.6	52.9	49.1	43.4	51.2	50.4	49.5	53.7	45.6	47.0	56.9	47.7	55.4	39.1	45.9	37.0	50.1	47.2	18.3	19.4	20.5	20.3	13.8	14.6	16.8	15.5	17.2	17.3
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"	Q8IZM8	3	88059274-88144665	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"				Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: , HPA049262: , HPA077939: "	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavourable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	18.2	8.9	10.9	13.2	11.6	15.1	12.6	18.6	13.3	13.5	11.8	9.8	13.5	9.7	14.0	12.1	14.4	9.5	10.8	10.4	11.3	8.5	11.0	15.4	11.8	12.3	13.9	10.3	14.7	9.5	12.8	21.8	11.9	11.1	12.8	9.8	10.7	12.5	10.2	13.9	14.9	13.4	13.1	15.8	10.1	10.0	12.3	14.8	22.2	13.4	9.4	12.0	16.6	14.6	2.6	2.3	10.0	2.0	6.5	4.0	1.7	4.6	1.9	3.4	4.7	7.5	6.2	3.0	6.1	5.6	4.1	5.9	2.9	2.8	7.4	4.3	5.3	3.1	3.6	5.7	8.3	4.5	2.0	4.6	2.6	2.1	5.6	5.2	5.2	6.1	5.7	4.6	5.5	5.6	3.1	6.0	9.3	3.6	5.2	4.8	1.8	3.2	3.6	2.3	3.5	4.0	6.1	2.5	2.2	4.5	3.6	11.7	4.9	4.1	6.3	9.2	6.1	34.5	4.4	6.9	4.7	5.2	7.5	5.0	5.9	10.0	1.9	2.7	2.9	2.0	3.3	1.8	3.2	4.0	2.3	2.6	3.9	2.6	2.7	6.5	1.4	1.1	2.2	1.7	10.9	11.6	18.6	13.3	11.3	8.5	13.9	10.3	11.1	14.8